Hip OA Relief with PRP & Integrative Chiropractic

Abstract

In this educational post, I walk you through a clear, evidence-based journey into hip osteoarthritis (hip OA): what it is, how it affects health, why it hurts, and what we can do about it using modern, research-backed strategies. I integrate my clinical observations and multidisciplinary approach as Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, to explain the anatomy of the hip, common pain patterns, examination methods, and current treatment options—from physical therapy and integrative chiropractic care to corticosteroid injections and platelet-rich plasma (PRP). I also present emerging data from leading researchers, compare outcomes across treatments, and detail a patient case that shows how precise diagnosis and thoughtful biomechanics-centered therapy can restore function and reduce pain. Finally, I offer practical protocols, physiological explanations, and the rationale behind each intervention so you know how and why these strategies work and when they are most effective.

Understanding Hip Osteoarthritis: Global Burden, Risk, and Mortality

As a family-trained clinician and integrative practitioner, I have seen hip OA evolve from a “common musculoskeletal complaint” into a global health concern with measurable impacts on mortality and quality of life. The data paint a compelling picture.

Between 1990 and 2019, the number of hip OA cases worldwide rose from approximately 740,000 to 1.6 million, reflecting an expanding global burden and consistent incidence growth across most regions.
High-income nations, especially in North America, show higher incidence and prevalence—a pattern likely driven by activity profiles, aging demographics, metabolic health, and diagnostic capture rates.
The disability-adjusted life years (DALYs) for hip OA continue to increase, emphasizing the condition’s meaningful impact on daily function and long-term health.

The physiological story behind these numbers is clear: symptomatic hip OA reduces physical activity, and reduced activity is tied to higher age-adjusted mortality. In large cohorts, hip OA has been associated with increased all-cause mortality (about 14%) and cardiovascular mortality (about 24%). These associations are not just correlations; they speak to a cycle where pain leads to inactivity, inactivity drives metabolic dysregulation, and systemic health declines follow.

Why this matters in the clinic: when you treat hip OA, you aren’t only treating pain—you are intervening on function, metabolic health, and longevity. Any successful plan must intelligently restore movement, reduce inflammation, and rebuild resilient biomechanics.

Hip Anatomy and Pain Patterns: Why Location Matters

To treat hip OA well, we need to understand the structure and the story it tells.

The hip is a ball-and-socket joint—the femoral head articulates with the acetabulum of the pelvis, stabilized by labrum, ligaments, and a powerful muscular envelope.
Key bony landmarks include the acetabulum, femoral neck, greater trochanter (gluteal tendon insertions), and sacroiliac (SI) joint—a crucial stabilizer in pelvic load transfer.
The region is rich in neurovascular and muscular structures, any of which can mimic or compound joint-origin pain.

Patients commonly describe:

Anterior hip and groin pain: classically hip joint–origin, often a C-shaped distribution wrapping the groin.
Lateral hip pain: more often greater trochanteric pain syndrome or gluteal tendinopathy.
Posterior hip/buttock pain: can arise from the SI joint, piriformis, hamstring origin, or referred lumbar sources—but up to 10% of true hip joint pathology can also present posteriorly.

The physiological underpinning:

Cartilage degeneration exposes subchondral bone, increasing mechanosensitive nociception.
Synovial inflammation (synovitis) increases pain mediators and joint effusion.
Biomechanical maldistribution—caused by weakness or altered motor control—overloads focal cartilage zones, accelerating wear and increasing pain.

Clinical takeaway: pain location guides initial hypotheses, but do not anchor prematurely—hip joint pathology can masquerade. If posterior pain persists despite typical SI or hamstring care, look deeper into the hip joint.

Hip Examination: Functional Findings That Guide Accurate Diagnosis

A thorough hip exam identifies motion deficits, reproduces joint-specific pain, and distinguishes hip-origin pain from adjacent structures.

Key elements I rely on:

Range of Motion: Internal and external rotation are highly informative. A reduction in internal rotation is characteristic of hip OA due to capsular fibrosis and osteophyte impingement.
Log Roll Test: Passive rolling of the leg identifies intra-articular irritability and capsular sensitivity.
Straight Leg Raise: Useful primarily for lumbar radicular patterns—helps differentiate hip from spine.
FABER (Flexion, ABduction, External Rotation): Reproduces hip joint or SI joint pain depending on localization. I always ask patients to pinpoint the location of the pain during this test.
FADIR (Flexion, ADduction, Internal Rotation): Often the most sensitive maneuver for intra-articular hip pathology, including OA and femoroacetabular impingement.

Physiological reasoning:

These maneuvers compress or tension specific regions of the hip capsule and labrum, eliciting pain from mechanoreceptors and nociceptors when pathology is present.
Motion restriction is frequently driven by capsular contracture, osteophytes, and intra-articular debris and is mirrored by predictable deficits in rotation.

Why Physical Therapy and Integrative Chiropractic Care Are Foundational

No injection or surgical tool can outrun poor biomechanics. My approach always begins with restoring movement capacity and load tolerance across the hip-pelvis-lumbar complex. This is where integrative chiropractic care shines alongside physical therapy.

What we aim to correct:

Pelvic alignment and SI joint stability: misalignment or instability amplifies shear forces into the hip.
Gluteal strength and timing: the gluteus medius/minimus stabilize frontal-plane load; deficits increase compressive stress on the joint and greater trochanter.
Core integration: a well-coordinated deep core (diaphragm, pelvic floor, transversus abdominis, multifidus) reduces axial load on the hip and improves lumbopelvic rhythm.
Hip mobility: safe restoration of internal rotation and extension enables proper gait mechanics and reduces anterior joint stress.

How integrative chiropractic care fits:

High-velocity, low-amplitude (HVLA) adjustments for the SI joint and lumbar segments can restore segmental motion and reduce neurogenic guarding.
Low-force mobilizations and instrument-assisted soft tissue techniques for the gluteal fascia, tensor fasciae latae, and iliopsoas reduce myofascial loading and pain.
Neuromuscular re-education and movement retraining align joint mechanics with muscular effort—this is where chiropractic clinical reasoning complements PT exercise progression.
Kinetic chain assessments identify upstream/downstream contributors (foot mechanics, thoracolumbar stiffness, asymmetrical gait cycles).

Why this works physiologically:

Improved alignment and neuromuscular timing reduce aberrant shear, compressive hotspots, and inflammatory signaling within the joint capsule.
Effective core-gluteal integration redistributes load across tissues adapted to force absorption, reducing stress on compromised cartilage.
Restored motion reduces synovial stagnation, enhancing nutrient diffusion and clearance of inflammatory byproducts.

My clinical observations:

Patients who commit to combined PT plus integrative chiropractic protocols progress more consistently, with fewer flares and better long-term function. In complex or athletic cases, this joint strategy is often the difference between symptom reduction and meaningful restoration of performance (Jimenez, n.d.-a; Jimenez, n.d.-b).

Corticosteroid Injections: Short-Term Relief, Diagnostic Utility

Corticosteroid injections into the hip joint are a longstanding tool for pain modulation and diagnostic clarity.

What the evidence shows:

Randomized trials indicate significant pain relief at approximately 3 months compared with saline or placebo, but benefits often diminish by 6 months.
Major societies, including the American Academy of Orthopaedic Surgeons, offer moderate-strength recommendations for use focused on short-term pain reduction and for diagnostic purposes.

Physiological rationale:

Corticosteroids suppress synovial inflammation by inhibiting phospholipase A2 and downstream eicosanoid pathways, thereby reducing prostaglandin and leukotriene production.
Reduced synovitis decreases joint effusion and intra-articular pressure, relieving nociceptive signaling.

Clinical reasoning:

I use a targeted diagnostic injection when the pain generator is unclear (hip vs. SI vs. lumbar vs. trochanteric tendinopathy). If pain transiently resolves after an intra-articular injection, it helps confirm that the symptoms originate from the hip joint.
In patients needing rapid symptom control to engage in rehabilitation, a single injection can jumpstart movement restoration, but it must be paired with biomechanics-focused care. Without strengthening and mobility retraining, benefits fade and may not alter the disease trajectory.

Platelet-Rich Plasma (PRP): Longer-Lasting Relief and Biological Repair Signals

PRP has emerged as a biologic option for hip OA with growing support from randomized controlled trials. While protocols vary, several consistent findings guide clinical practice.

Key insights from pooled studies:

Across multiple randomized controlled trials, PRP reduces pain at several time points, with low- to moderate-quality evidence supporting clinically meaningful improvements over 3–6 months.
Single-injection protocols often perform as well or better than series protocols, possibly due to reduced post-injection flares and more precise dosing.
Lower volumes are associated with better outcomes and fewer adverse events. In practice, volumes of 3–6 mL are well tolerated; large-volume injections (≥15 mL) increase discomfort without clear benefit.

Why PRP works physiologically:

PRP concentrates platelets and growth factors (e.g., PDGF, TGF-β, VEGF, IGF-1), which can modulate inflammation, enhance matrix synthesis, and support chondral homeostasis.
Leukocyte-poor PRP in joints may reduce levels of catabolic cytokines (IL-1β, TNF-α) more effectively than leukocyte-rich formulations, thereby decreasing synovial irritation.
Rebalancing the joint environment helps calm nociceptive signaling and may slow degenerative cascades.

Comparative outcomes:

Systematic reviews comparing corticosteroids, hyaluronic acid, and PRP frequently show PRP achieving the lowest pain scores at 6 months, while steroids offer earlier relief with shorter durability.
The conclusion: use steroids for diagnostic and short-term flare control, and consider PRP for medium-term pain reduction and functional gains—always coupled with integrative rehabilitation strategies.

Protocol design:

I favor single, ultrasound-guided intra-articular injections of leukocyte-poor PRP in the 3–6 mL range.
Post-procedure, I avoid NSAIDs for 5–7 days to preserve platelet signaling, focusing on a gentle range of motion, progressive strength work, and neuromotor retraining as pain allows.
Based on patient response and goals, repeat injections can be considered at 4–6 months, though many patients do well with a single carefully designed protocol.

Case Study: When Hip OA Masquerades as Spine Pain

I want to share a case that exemplifies how careful diagnosis and integrative care change outcomes.

A 22-year-old college linebacker transferred into our program with a 6-month history of “low back pain.” He had undergone multiple epidural steroid injections, medial branch blocks, and sciatic injections with no lasting benefit.
On exam, his hip internal rotation was limited to about 15 degrees, and FABER reproduced deep anterior pain. Lumbar spine imaging showed an L5-S1 disc herniation—consistent with prior studies—but it did not explain his persistent pain patterns.
Focused hip imaging revealed cortical irregularity near the femoral head-neck junction, suggestive of intra-articular pathology.

Our plan:

Begin PT focused on core and gluteal strengthening with controlled restoration of hip mobility.
Perform a diagnostic intra-articular injection—his pain resolved, confirming hip joint origin.
Follow with a PRP injection during the off-season (about three and a half months later), coupled with progressive biomechanics work.

Outcome:

He completed the next three years without lost time due to hip or lumbar complaints. The take-home point: accurate identification of the pain generator and integration of chiro-PT protocols enable biologics such as PRP to deliver meaningful, durable relief.

Building a Comprehensive Hip OA Treatment Plan: Step-by-Step

Here is how I structure care for hip OA patients, grounded in physiology and research:

Assessment and Differential:
- Clarify pain location: anterior (intra-articular), lateral (gluteal/trochanteric), posterior (SI/lumbar—but keep hip in mind).
- Perform targeted tests: FADIR, FABER, log roll, gait analysis.
- Use imaging judiciously: weight-bearing X-rays, targeted MRI for labrum/osteophytes.
Foundational Integrative Care:
- Begin PT plus chiropractic early:
  - Pelvic/SI alignment strategies (HVLA when indicated, gentle mobilization).
  - Gluteal and deep core strengthening to reduce shear and improve load sharing.
  - Hip mobility restoration—internal rotation, extension—without provoking flares.
  - Myofascial release for TFL, iliopsoas, piriformis, and adductors.
Pain Modulation:
- Use corticosteroid injections for short-term control and diagnostic clarity.
- Consider PRP for medium-term relief and potential improvement in biological terrain.
Progression:
- Layer neuromotor retraining (single-leg stance drills, step-down control, hip-hinge mechanics).
- Address kinetic chain issues: foot mechanics, thoracolumbar mobility, contralateral hip stability.
Long-Term Health:
- Encourage consistent moderate physical activity to counteract the inactivity–mortality link.
- Support metabolic health with anti-inflammatory nutrition and sleep strategies; metabolic syndrome worsens OA outcomes.

Why this works:

The combination of reduced inflammation (steroids or PRP) and restored biomechanics (PT and chiropractic) interrupts the pain–inactivity cycle.
Over time, patients build tissue tolerance, restore joint motion, and regain confidence in movement—crucial for maintaining function and preventing relapse.

Biologics in Hip OA: Dosing, Volume, and Future Directions

Key open questions—and how we navigate them now:

Optimal platelet dose: Current evidence suggests benefit from leukocyte-poor formulations; higher platelet counts might aid repair signaling, but must be balanced against synovial reactivity.
Volume considerations: Clinical observations and pooled data indicate that lower volumes (3–6 mL) improve comfort and outcomes compared with higher volumes. Larger volumes can elevate intra-articular pressure and irritate the joint.
Frequency: Several analyses favor single-injection strategies, possibly due to reduced cumulative synovial irritation.
Concentrated plasma: Novel systems aim to enrich anti-inflammatory and anti-degenerative proteins while minimizing leukocytes—promising in theory, but we need standardized reporting and head-to-head trials to establish superiority.

From bench to bedside:

Biologic therapies target the catabolic milieu of OA—reducing inflammatory cytokines, encouraging matrix maintenance, and supporting chondrocyte survival. The best outcomes occur when biologics are a bridge to better mechanics, not a stand-alone fix.

Practical Protocol: My Clinic Approach to PRP for Hip OA

Here is a simplified overview of how I implement PRP:

Patient Selection:
- Symptomatic hip OA with functional limitations despite conservative care.
- No active infection, coagulopathy, or uncontrolled systemic inflammation.
Preparation:
- Use a benchtop processing system to obtain leukocyte-poor PRP.
- Target 3–6 mL intra-articular injection volume.
Procedure:
- Ultrasound-guided injection for precision and safety.
- Post-procedure, avoid NSAIDs for 5–7 days; consider acetaminophen for discomfort.
Rehabilitation:
- Initiate gentle ROM within 24–72 hours, as tolerated.
- Progress gluteal/core strengthening, balance, and hip control drills.
- Incorporate chiropractic mobilization for SI/lumbar segments as needed to normalize load transfer.
Follow-Up:
- Reassess function and pain at 6–8 weeks and 3–6 months.
- Consider repeat PRP at 4–6 months if pain/function plateaus and patient goals demand.

Physiological reasoning:

This cadence respects platelet signaling timelines, reduces synovial irritation, and uses the post-injection window to re-pattern movement for lasting benefit.

Clinical Pearls and Red Flags

If posterior hip pain persists after targeted SI/piriformis/hamstring care, suspect intra-articular hip pathology—retest with FADIR and guided imaging.
Loss of internal rotation is a small but potent predictor of hip joint involvement.
Avoid chasing pain with serial injections without improving mechanics—the hip demands a systems approach.
Encourage consistent activity—the mortality data are a reminder that movement is medicine.

Conclusion: A Modern Framework for Hip OA That Puts Biomechanics First

Hip OA is more than cartilage loss—it is a dynamic interplay between inflammation, mechanics, and behavior. The latest research consistently shows:

Corticosteroids provide short-term relief and diagnostic help.
PRP offers more durable pain reduction at 6 months for many patients.
The best outcomes come when we pair biologics with integrative chiropractic care and targeted physical therapy to restore motion, stability, and confidence.

In my practice, this combined approach delivers meaningful improvements in pain and function, supports systemic health through increased activity, and respects the hip’s complexity. When we treat the hip as both a joint and a node in a kinetic chain, we change lives—not just symptoms.

References

American Academy of Orthopaedic Surgeons Clinical Practice Guidelines on Osteoarthritis of the Hip (American Academy of Orthopaedic Surgeons, n.d.)
Global Burden of Disease Study Findings on Musculoskeletal Disorders (GBD Collaborators, 2019)
PRP in Osteoarthritis: Mechanisms and Clinical Outcomes (Filardo, S., & Kon, E., 2020)
Platelet-Rich Plasma vs Corticosteroid Injections for Hip OA: Systematic Review and Meta-Analysis (Dai, W., et al., 2021)
Physical Activity, Osteoarthritis, and Mortality Risk (Booth, F. W., Roberts, C. K., & Laye, M. J., 2019)
Hip Examination and Special Tests in Clinical Practice (American Academy of Family Physicians, 2017)
Integrative Chiropractic and Multidisciplinary Care in Musculoskeletal Conditions (Goertz, C. M., et al., 2019)
Chondroprotection and Biologic Modulation in OA (Mobasheri, A., et al., 2020)
Dr. Alexander Jimenez Clinical Observations and Practice Insights (Jimenez, A., n.d.-a)
Professional Profile and Publications of Dr. Alexander Jimenez (Jimenez, A., n.d.-b)

May 27, 2026

Sports Medicine and Its Potential Benefits in PRP Therapy

Explore the role of PRP therapy in sports medicine in speeding up recovery and supporting athletes in peak condition.

PRP and Protein Concentrate Therapy

As a clinician deeply invested in integrative medicine, I, Dr. Alexander Jimenez, am constantly exploring innovative, evidence-based therapies to enhance patient outcomes. My work across various disciplines—including as a Doctor of Chiropractic (DC), Advanced Practice Registered Nurse (APRN), and Board-Certified Family Nurse Practitioner (FNP-BC)—has shown me the profound need for comprehensive treatment strategies. Today, I want to share insights into a powerful combination therapy that is changing the landscape of sports medicine and regenerative care: Platelet-Rich Plasma (PRP) enhanced with Protein Concentrate (PC). This approach represents a significant step forward, offering more than just temporary relief by addressing the underlying biochemical environment of an injury. We will delve into the science, explore the clinical applications, and discuss how this therapy, when integrated with chiropractic care and structured rehabilitation, can create superior, long-lasting results for our patients.

Abstract: Enhancing Regenerative Outcomes

This post explores the synergistic use of Platelet-Rich Plasma (PRP) and Protein Concentrate (PC) in managing musculoskeletal conditions. We will begin by defining Protein Concentrate, a derivative of platelet-poor plasma, and detailing its key anti-inflammatory and regenerative components, such as Alpha-2-Macroglobulin (A2M) and various growth factors. I will present the scientific rationale for combining these therapies, highlighting how the anti-catabolic properties of PC complement the anabolic effects of PRP. We will examine compelling research, including a pivotal study demonstrating long-term benefits for knee osteoarthritis, and discuss how to apply these findings in a clinical setting. This educational journey will cover patient selection, specific injection protocols for joints such as the knee and shoulder, and the critical role of data collection in refining our practice. Finally, I will explain how this advanced regenerative approach integrates seamlessly with a comprehensive care model that includes chiropractic adjustments, targeted rehabilitation, and other modalities to optimize healing and differentiate a practice within the competitive healthcare landscape.

Understanding Protein Concentrate: The Other Half of the Equation

In my practice, I frequently use Platelet-Rich Plasma (PRP), a therapy well-known for its healing properties. PRP is derived from a patient’s own blood and contains a high concentration of platelets, which release growth factors that stimulate tissue repair. But what about the other part of the blood that is separated during this process—the platelet-poor plasma (PPP)? For a long time, this component was often discarded. However, leading researchers have shown us that PPP is a treasure trove of beneficial molecules.
When we run platelet-poor plasma through a specialized filtration system, we obtain what is known as Protein Concentrate (PC). This process isolates and concentrates powerful proteins that play a crucial role in modulating the joint environment.

Key Components of Protein Concentrate

So, what makes Protein Concentrate so valuable? It’s all about its molecular makeup. The key players include:
Alpha-2-Macroglobulin (A2M): This is the star of the show. A2M is a very large protein (around 720 kilodaltons) that acts as a powerful protease inhibitor. In an inflamed or arthritic joint, destructive enzymes called proteases are overactive, breaking down cartilage and perpetuating a cycle of degradation and pain. When injected into a joint, A2M acts like a molecular trap, irreversibly binding to these proteases and neutralizing their destructive activity. This has a profound anti-catabolic effect, essentially stopping the breakdown process in its tracks.
Interleukin-1 Receptor Antagonist (IL-1Ra): Interleukin-1 (IL-1) is a potent inflammatory cytokine that drives pain, swelling, and cartilage degradation in conditions like osteoarthritis. PC is rich in IL-1Ra, a naturally occurring protein that blocks IL-1 receptor signaling. By preventing IL-1 from binding to its receptor, IL-1Ra effectively shuts down this major inflammatory pathway, leading to significant symptom relief.
Growth Factors: While PRP is the primary source of growth factors, PC also contains beneficial ones, including:
Vascular Endothelial Growth Factor (VEGF): Promotes the formation of new blood vessels, which is essential for delivering nutrients and oxygen to healing tissues.
Epidermal Growth Factor (EGF): Stimulates our own adult mesenchymal stem cells, encouraging them to participate in the repair process.
Platelet-Derived Growth Factor (PDGF-BB): Another powerful stimulant for mesenchymal stem cell activity.
By combining the anabolic (tissue-building) signals from PRP with the anti-catabolic (breakdown-blocking) and anti-inflammatory power of PC, we create a much more comprehensive and synergistic treatment environment within the joint.

The Clinical & Economic Case for Combining PRP and Protein Concentrate

In today’s healthcare market, especially for cash-based services like regenerative medicine, it’s not enough to offer a standard treatment. Patients are discerning; they want the best possible outcomes and are willing to invest in treatments that provide superior, lasting value. This is where offering a combination of PRP and Protein Concentrate becomes a powerful practice differentiator.
Think of it in terms of a “good, better, best” model:
Good: A standard PRP injection. This is effective and offered by many practitioners.
Better/Best: A combined PRP + PC injection. This premium service is justified by its enhanced mechanism of action—it doesn’t just stimulate repair; it actively protects the joint from further damage. This provides faster comfort, improved longevity, and a stronger rationale for a premium price point.
From my clinical observations, patients who opt for the combined therapy often experience more rapid pain relief and a more durable outcome. When we further stack the deck in the patient’s favor by integrating this with a full rehabilitation program—including chiropractic care, laser therapy, or shockwave therapy—we create a system designed for success. As a practitioner, this allows you to build a reputation on superior results, the ultimate differentiator.
The economics are also compelling. While adding PC to a PRP procedure increases the patient’s fee, the incremental cost of goods for the PC filter is relatively low. This results in a significantly higher profit margin for the procedure, allowing a practice to thrive while delivering a top-tier service.

Sports Injury Rehabilitation- Video

Evidence-Based Success: Long-Term Results for Knee Osteoarthritis

We must ground our clinical decisions in solid evidence. One of the most compelling pieces of research in this area comes from a 2017 paper by M.S. Mautner, K., & Colberg, R. E. (2017). They conducted a study on 82 knees with moderate-to-severe (Grades II, III, and IV) osteoarthritis. These were not “cherry-picked” easy cases; they represented the real-world challenges we see in our clinics.
The patients were treated with what the study termed “autologous protein solution,” which is essentially the Protein Concentrate we are discussing. The results were remarkable:
Patients showed statistically significant improvements in pain and function at three months.
Most impressively, these positive results were sustained for up to three years after a single injection.
This is a game-changer. We know from other research, such as Mei-Dan et al. (2012), that the benefits of PRP alone for knee osteoarthritis typically last around 12 to 18 months. The Mautner study suggests that adding the anti-catabolic and anti-inflammatory power of PC can potentially double the duration of effect. This provides immense value to the patient, who is looking for a long-term solution, not just a temporary fix. While the best results were seen in patients with Grade II and III osteoarthritis, even those with “bone-on-bone” Grade IV arthritis saw benefits.
Of course, science is never unanimous. Other studies have shown more mixed results, and it’s our responsibility as clinicians to present a balanced view. Transparency builds trust. I tell my patients that while the evidence is strong and my clinical experience is positive, no single therapy is a cure-all. This honest, evidence-informed approach enhances our credibility and strengthens the doctor-patient relationship.

Clinical Application: Protocols and Patient Selection

Knowing the “what” and “why” is crucial, but the “how” is what makes the difference in practice. Proper patient selection and meticulous technique are paramount.

Patient Selection and Preparation

Ideal Candidates: Patients with mild-to-moderate (Grade II-III) knee osteoarthritis are often the best candidates. We also see excellent results in chronic tendinopathies and certain shoulder conditions.
Pre-Injection Aspiration: If a joint, particularly the knee, has a significant effusion (excess fluid), it is critical to aspirate it before injecting. This “sludge” is filled with inflammatory cytokines and proteases. Removing it cleans the slate, allowing the PRP and PC to work in a less hostile environment.

Injection Volume and Technique

It’s important to understand the volume capacity of different joints. Research presented at conferences has shown that the knee can hold a surprisingly large volume, close to 100 mL, before intra-articular pressure rises dangerously. Therefore, a 10 mL injection (e.g., 5 mL of PRP and 5 mL of PC) is very safe and well-tolerated. Patients might feel a sense of fullness, but it is not harmful.
My general volume protocols are:
Knees & Shoulders: These are larger-volume joints. I typically use a 1:1 ratio of PRP to PC. For example, 5 mL of PRP combined with 5 mL of PC for a total of 10 mL injection.
Hips, Ankles & Wrists: These are lower-volume joints. I adjust the ratio to prioritize the anabolic signal of PRP while still getting the anti-catabolic benefit of PC. For a hip, I might use a 3:1 ratio, such as 3-4 mL of PRP and 1 mL of PC.

Specific Conditions

Chronic Tendinopathy (e.g., Achilles, Patellar): For these conditions, I perform an intratendinous injection of PRP to stimulate healing within the damaged tendon fibers. I then bathe the surrounding area (the paratenon) with Protein Concentrate to quell the local inflammation that is often a major source of pain.
Adhesive Capsulitis (Frozen Shoulder): This is one of my favorite applications. The traditional treatment often involves a corticosteroid injection to reduce pain enough for physical therapy to be tolerated. However, we can achieve a better, safer outcome. The protocol involves performing a hydrodilation—stretching the contracted shoulder capsule with sterile saline—followed by an intra-articular injection of Protein Concentrate. The PC’s potent anti-inflammatory effects, especially IL-1Ra, dramatically reduce the inflammation driving the condition, providing a window for effective, less painful rehabilitation.

The Indispensable Role of Chiropractic Care and Rehabilitation

A regenerative injection, no matter how advanced, is only one piece of the puzzle. At my clinic, we are staunch advocates for a holistic approach. Simply performing an injection and sending the patient on their way is what I call “drive-through” medicine, and it’s a disservice to the patient. True healing requires a comprehensive strategy.
This is where integrative chiropractic care becomes essential.
Restoring Biomechanics: An injury or degenerative condition doesn’t happen in a vacuum. It is almost always associated with or exacerbated by underlying biomechanical faults—poor joint alignment, muscle imbalances, and dysfunctional movement patterns. Chiropractic adjustments are crucial for restoring proper joint mechanics in the spine and extremities. If we inject a knee but fail to address the pelvic imbalances or foot pronation that caused the abnormal stress on that knee, the problem will inevitably return.
Improving Neurological Function: Adjustments also have a profound effect on the nervous system, improving proprioception (the body’s sense of its position in space) and normalizing nerve signaling to the muscles that support the joint. This creates a more stable and functional environment for the healing tissues.
Targeted Rehabilitation: Following the injection, a structured rehabilitation program is non-negotiable. This must include specific exercises to strengthen supporting muscles, stretch tight structures, and retrain proper movement patterns. The injection creates the optimal biochemical environment for healing, but the physical work of rehab provides the necessary mechanical stimuli to guide tissue remodeling.

Data Collection: The Key to Clinical Excellence

How do you know if your treatments are working? How can you confidently tell a patient what to expect? The answer is data. In my practice, we collect outcome data on every single regenerative procedure. Whether you use a simple spreadsheet or a sophisticated registry service, the act of collecting data is what transforms you from a practitioner who is guessing into one who knows.
My own data comparing PRP-only treatments to PRP + PC treatments for knee osteoarthritis show a clear advantage for the combination therapy. Patients in the PRP + PC cohort demonstrate a greater reduction in pain scores and a faster return to function. For example, we can tell a patient that on average, they can expect a 24-point improvement on a specific outcome score by a certain time point. This is powerful. It allows you to:
Set realistic patient expectations.
Refine and improve your protocols.
Leverage your own results during patient consultations to build immense confidence and trust.
When I sit with a patient, I can show them our clinic’s data for patients with their exact condition. This is infinitely more valuable than citing a study done by someone else in a different setting. Without your own data, you are flying blind.

Final Thoughts: Delivering a Superior Standard of Care

In a world where PRP is becoming a commodity, you can set your practice apart by delivering a structured, evidence-informed, and comprehensive system of care. Combining the anabolic power of PRP with the anti-catabolic and anti-inflammatory protection of Protein Concentrate creates a synergistic therapy with the potential for significantly better and longer-lasting outcomes.
This is not just about an injection. It is about an integrated protocol that you have developed, tested, and proven with your own data. It’s about understanding biomechanics through a chiropractor’s eye, guiding rehabilitation with a therapist’s knowledge, and managing biology with cutting-edge regenerative techniques. This distinction—delivering an integrated system of excellence rather than just a single product—is the foundation of a premium practice and, most importantly, the key to achieving the best possible results for the patients who place their trust in us.

References

Mautner, K., & Colberg, R. E. (2017). The effects of an autologous conditioned plasma injection on pain and function in patients with knee osteoarthritis. PM&R, 9(5), S94. https://www.pmrjournal.org/article/S1934-1482(17)30283-0/fulltext
Mei-Dan, O., Carmont, M. R., Laver, L., Mann, G., Maffulli, N., & Nyska, M. (2012). Platelet-rich plasma or hyaluronate in the management of osteochondral lesions of the talus. The American Journal of Sports Medicine, 40(3), 534–541. https://journals.sagepub.com/doi/10.1177/0363546511431238

SEO Tags: Protein Concentrate, PRP Therapy, Integrative Chiropractic Care, Knee Osteoarthritis, Regenerative Medicine, Alpha-2-Macroglobulin, A2M, Sports Medicine, Dr. Alexander Jimenez, Functional Medicine, Chronic Tendinopathy, Adhesive Capsulitis, Evidence-Based Practice, Patient Outcomes, Joint Pain Treatment, Non-Surgical Treatment

May 26, 2026

Cardiometabolic Health Solutions With GLP-1 Therapy

Discover the impact of GLP-1 therapy on cardiometabolic health and how it can benefit individuals seeking better wellness.

Abstract: A New Paradigm in Metabolic Health

Welcome to our educational post on the revolutionary class of medications known as GLP-1 receptor agonists. As a practitioner deeply rooted in integrative and functional medicine, with a diverse background spanning chiropractic (DC), advanced practice nursing (APRN, FNP-BC), and functional medicine (CFMP, IFMCP), my primary goal has always been to find the most effective, evidence-based strategies to improve my patients’ health. My clinical observations at our El Paso and San Antonio clinics, coupled with the latest research, continually point toward a more integrated and holistic approach to chronic disease. This post will serve as your guide, translating complex clinical trials and physiological mechanisms into an easy-to-understand narrative. We will delve into how these powerful agents work, explore the landmark cardiovascular outcomes trials (CVOTs) that revealed their ability to protect the heart and kidneys, and differentiate among the available options, such as semaglutide (Ozempic/Wegovy) and the dual-agonist tirzepatide (Mounjaro/Zepbound). Furthermore, we will delve into the practical aspects of using these therapies, including managing side effects, understanding safety considerations, and exploring their investigational uses in everything from neuroprotection to fertility. Most importantly, we’ll connect these pharmacological advancements back to the core principles of integrative health, examining how integrative chiropractic care is essential for maximizing patient outcomes and achieving true, sustainable well-being.

Rethinking Diabetes: Beyond Glucose-Centric Care

In my years of practice, I’ve seen firsthand the devastating impact of diabetes on my patients’ lives. For decades, the management of type 2 diabetes was primarily focused on lowering blood glucose levels. However, we now understand that this is only one piece of a much larger puzzle. It’s a reality underscored by stark statistics. We know that atherosclerotic cardiovascular disease (ASCVD)—which encompasses coronary heart disease, stroke, and peripheral arterial disease—is the leading cause of death for individuals with type 2 diabetes. In fact, more than 70% of elderly patients with diabetes will likely succumb to heart disease or a stroke. The prognosis following a heart attack is significantly poorer for someone with diabetes compared to someone without, and alarmingly, these outcomes often remain bleak even when blood glucose levels are considered “well-controlled.”
This has forced a critical shift in our clinical strategy. The old model, which I call the “glucose-centric” approach, is no longer sufficient. We must move toward a multifaceted management plan that reduces overall risk. This requires a collaborative and integrative effort.

Pillars of Modern Diabetes Management

The world’s leading medical bodies, including the American College of Cardiology (ACC), the American Heart Association (AHA), the American Diabetes Association (ADA), and the Kidney Disease Improving Global Outcomes (KDIGO) group, are all aligned on this new, comprehensive approach. It’s no longer just about the A1c. Our focus must be on:
Lifestyle Management: Foundational changes in diet and physical activity.
Diabetes Self-Management Education: Empowering patients with the knowledge to control their condition.
Cardiovascular Risk Reduction: Aggressively managing blood pressure, cholesterol (lipids), and, of course, glucose levels.
Weight Management: Addressing excess weight as a key driver of metabolic dysfunction.
Smoking Cessation: Eliminating a major accelerator of cardiovascular disease.
This holistic view is the cornerstone of effective, 21st-century care.

Clinical Case Study: The Challenge of “Over-Basalization”

To illustrate these concepts, let’s consider a case similar to many patients I see in my clinic. We’ll call her Naomi.
Naomi is a 66-year-old female who has been living with type 2 diabetes for 12 years. Despite being on a robust medication regimen, her health is not where it needs to be.
A1c: Her last A1c was 8.3%, well above the target of less than 7%.
Comorbidities: She has high cholesterol (hyperlipidemia), hypertension, and protein in her urine (proteinuria), a sign of early kidney stress.
Medications:
Metformin 1000 mg twice daily.
Degludec insulin (a basal insulin): 66 units daily.
An SGLT-2 inhibitor (a class of oral diabetes medication).
A statin for cholesterol.
An ARB for blood pressure.
Weight: She weighs 220 pounds and is 5’9 “, giving her a BMI of 32.5, placing her in the obese category.
Glucose Readings:
Her fasting glucose levels are between 140 and 160 mg/dL. The goal is typically 90-130 mg/dL.
Her postprandial (after-meal) glucose levels are 160-170 mg/dL. While the ADA goal is under 180 mg/dL, many specialists, including myself, prefer to see this number much lower, ideally under 140 mg/dL two hours after a meal.

The Problem: Over-Basalized and Still Not at Goal

Naomi’s case highlights a common clinical problem: “over-basalization.” She is taking a very high dose of basal insulin, yet her A1c and fasting glucose are still too high. A simple clinical calculation I use is to multiply a patient’s weight in kilograms by 0.5. For Naomi, who weighs 100 kg, this suggests that a basal insulin dose above 50 units may be excessive. At 66 units, she is clearly over-basalized.
The high basal insulin dose isn’t effectively controlling her blood sugar, and it’s likely contributing to her difficulty with weight management. The logical next step in a traditional model might be to add prandial (mealtime) insulin to cover her post-meal glucose spikes. However, this is where we can intervene more intelligently. Before adding more insulin, which often leads to further weight gain and increased risk of hypoglycemia, we should consider a GLP-1 receptor agonist. This approach leverages the body’s natural “incretin effect” to address the very issue Naomi is struggling with: postprandial hyperglycemia.

Understanding GLP-1 Receptor Agonists: The Incretin Effect

To truly appreciate these medications and understand why a GLP-1 agent is such a powerful tool, we need to talk about the “incretin effect.” This term describes a fascinating physiological process that is glucose-dependent, meaning these hormones act primarily when glucose is present. Our bodies naturally produce incretin hormones, specifically GLP-1 (Glucagon-Like Peptide-1) and GIP (glucose-dependent insulinotropic polypeptide), which are synthesized and released by specialized “L-cells” in the jejunum, a part of our small intestine.
This release is triggered by the presence of food in the gut. When you eat a meal, these hormones are secreted into the bloodstream, orchestrating a multi-pronged response:
Stimulates Insulin Secretion: It signals the pancreas to increase insulin secretion, but only in a glucose-dependent manner. This means it only works when blood sugar is high, dramatically reducing the risk of hypoglycemia compared to insulin or other medications.
Suppresses Glucagon Release: It signals the pancreas to stop releasing glucagon, a hormone that prompts the liver to produce more glucose. This prevents unnecessary glucose from entering the bloodstream.
Slows Gastric Emptying: It slows down the rate at which food leaves the stomach. This makes you feel full sooner and for longer, helping to control appetite and prevent sharp, rapid spikes in blood sugar after meals.
Promotes Satiety: It acts directly on the brain to reduce appetite and increase feelings of fullness.
In individuals with type 2 diabetes, this natural incretin effect is often blunted or, in some cases, completely absent. They produce very low levels of their native GLP-1 hormone. This deficiency leads to insufficient insulin secretion after meals and a failure to suppress glucagon. The result is the hallmark hyperglycemia we see in diabetes. GLP-1 receptor agonists are medications designed to mimic the action of our own GLP-1, but they are engineered to last much longer in the body, restoring and amplifying these beneficial effects.

Mechanisms of Action: More Than Just Blood Sugar Control

The mechanisms of these drugs are multifaceted and explain not only their benefits but also their common side effects.
Gastrointestinal System: In the presence of a GLP-1 agonist, gastric emptying is significantly slowed. This delay is a primary reason patients feel full for longer, which naturally leads to reduced food intake and contributes to weight loss. Unfortunately, this slowing effect can also cause side effects like mild nausea and occasionally vomiting, especially in individuals with a history of gastroparesis. Some patients may experience diarrhea, while others report constipation or mild abdominal pain.
Central Nervous System (Brain): We believe that these small-molecule drugs can cross the blood-brain barrier and act directly on the brain’s appetite centers, such as the hypothalamus. This central action helps to decrease appetite and reduce food cravings, providing another powerful mechanism for weight loss. The feeling of prolonged satiety is likely a combination of this central effect and the delayed gastric emptying.
Pancreas: In the pancreas, GLP-1 agonists stimulate glucose-dependent insulin secretion from the beta cells. Simultaneously, they suppress glucagon secretion. By lowering glucagon, they help reduce the liver’s inappropriate production and release of stored glucose, a common dysfunction in type 2 diabetes.

The “Ominous Octet” and the Power of GLP-1s

In 2009, the renowned endocrinologist Dr. Ralph DeFronzo published a seminal paper describing the “Ominous Octet”—eight core pathophysiological defects that contribute to type 2 diabetes (DeFronzo, 2009). This framework helps us understand the complexity of the disease. What is remarkable is that GLP-1 receptor agonists address six of these eight defects very effectively. Their widespread use makes them among the most comprehensive therapies available.

Choosing the Right GLP-1 Agonist: A Comparative Look

The family of GLP-1 agents has grown, offering us a variety of options with distinct profiles. It’s crucial to choose an agent that aligns with the individual patient’s needs. Let’s look at the data from leading researchers to understand the impact of these medications. When we compare these agents, we see a clear progression in efficacy:
Liraglutide resulted in a weight loss of about 2.7 kilograms and a just under 1% reduction in HbA1c.
Dulaglutide improved upon this, showing an average weight loss of 4.6 kilograms.
Semaglutide represented a significant leap forward, demonstrating an average weight loss of 6.4 kilograms and a more robust HbA1c reduction of between 1.8% and 2.1%.
Then came tirzepatide, a dual GIP and GLP-1 receptor agonist, which has shown truly remarkable results. In clinical trials, it was associated with an average weight loss of 11.2 kilograms—almost double that of semaglutide—and an impressive 2.3% reduction in HbA1c.
It’s crucial to note that these powerful results, particularly for weight loss, were observed at the higher doses approved by the FDA during the drug approval process. Here’s a breakdown of the key players, based on the latest research and FDA indications as of May 21, 2026:
Medication (Brand Name)
Key Indications & Benefits
A1c Lowering
Typical Weight Loss
Semaglutide (Ozempic/Rybelsus)
Type 2 Diabetes, Weight Loss (Wegovy), MACE Reduction, Nephropathy Protection. Semaglutide is a potent agent with robust evidence of cardiovascular and kidney benefits.
~1.5-2.0%
~15% of body weight
Tirzepatide (Mounjaro/Zepbound)
Type 2 Diabetes, Weight Loss, OSA. This is a “twincretin,” a dual GLP-1/GIP agonist, showing the highest efficacy for both glucose lowering and weight loss. Cardiovascular outcome trials are ongoing but look promising.
>2.0%
>20% of body weight
Dulaglutide (Trulicity)
Type 2 Diabetes, MACE Reduction, Nephropathy Protection. A reliable weekly injection with proven cardiovascular and kidney benefits, though with more moderate weight loss compared to newer agents.
~1.0-1.5%
~3-5 kg
Liraglutide (Victoza)
Type 2 Diabetes, MACE Reduction, Nephropathy Protection. One of the first GLP-1s with proven cardiovascular benefits, but it requires a daily injection. Weight loss is more modest. A higher dose is available for weight loss (Saxenda).
~1.1%
~2.5 kg
Exenatide (Byetta/Bydureon)
Type 2 Diabetes. One of the earliest GLP-1s. It is effective for glucose control but has less impact on weight and lacks the proven cardiovascular protection of newer agents.
<1.0%
~2.9 kg
MACE = Major Adverse Cardiovascular Events (heart attack, stroke, cardiovascular death). OSA = Obstructive Sleep Apnea.

When I select a GLP-1 agonist for a patient, I’m not just looking at the A1c. For Naomi, who has hypertension and proteinuria, choosing an agent with proven MACE reduction and nephropathy protection like semaglutide (Ozempic) or dulaglutide (Trulicity) would be a critical part of a comprehensive strategy. Given her significant need for weight loss and A1c reduction, semaglutide or tirzepatide would be the top consideration.

Cardiovascular Outcomes Trials (CVOTs): The Game-Changer

The history of diabetes medications is marked by a pivotal moment in 2008. Following safety concerns with earlier drugs, the FDA mandated that all new diabetes drugs undergo large, long-term Cardiovascular Outcomes Trials (CVOTs). The goal was to demonstrate that these new drugs did not harm the cardiovascular system.
What happened next was completely unexpected and revolutionized our field. Not only were these drugs safe, but they also provided robust cardiovascular risk reduction. This discovery shifted the paradigm from “just diabetes drugs” to essential tools for cardiologists and nephrologists. The GLP-1 receptor agonists soon followed with their own impressive CVOT data:
REWIND Trial (Dulaglutide): Showed a 12% reduction in major adverse cardiovascular events (MACE).
LEADER Trial (Liraglutide): Showed a 13% reduction in MACE.
SUSTAIN-6 Trial (Subcutaneous Semaglutide): Showed a remarkable 26% reduction in MACE.
These large, multi-year, double-blind, placebo-controlled studies involving thousands of patients solidified the role of these medications as cornerstones of cardio-renal-metabolic care. We now view metabolic disease through the lens of the cardio-renal-metabolic (CRM) triad. These systems are bidirectionally linked; a problem in one inevitably affects the others.

How Professional Guidelines Position GLP-1 Agonists

The American Diabetes Association (ADA) has recognized the profound benefits of these medications. The 2025 ADA guidelines, published annually in Diabetes Care, place a strong emphasis on GLP-1 receptor agonists, especially for certain patient populations (ElSayed et al., 2024).
The ADA treatment algorithm is divided into two main pathways:
The Left-Hand Pathway: For patients with established atherosclerotic cardiovascular disease (ASCVD), heart failure, or chronic kidney disease (CKD), or those at very high risk. For these patients, a GLP-1 receptor agonist is now strongly favored as a primary agent, sometimes even before metformin.
The Right-Hand Pathway: For patients whose primary needs are glycemic control and weight management but who do not have the high-risk cardiovascular or kidney profile.
For patients with CKD, SGLT2 inhibitors are often the first choice. However, certain GLP-1 agonists, specifically semaglutide, have also earned an indication for kidney protection. The FLOW trial, stopped early due to overwhelmingly positive results, demonstrated that semaglutide reduced the risk of major kidney disease events and cardiovascular death by 24% in people with type 2 diabetes and CKD.

Balancing Body and Metabolism- Video

Navigating the Switch: A Guide to Changing GLP-1 Agonists

As a clinician committed to patient-centered care, I often encounter scenarios in which a medication switch is considered. A recent case involved a patient, we’ll call her Tammy, who was on Trulicity (dulaglutide) but wasn’t achieving her desired weight loss. Through shared decision-making, we explored a switch. This requires a careful, evidence-informed approach.
Switching from Trulicity (dulaglutide) to Ozempic (semaglutide): To switch from a 1.5 mg dose of dulaglutide, I would begin her on semaglutide 0.5 mg weekly. This conservative start minimizes side effects. After a month, if she tolerates it well, we could increase her to a weekly dose of 1 mg.
Switching from Trulicity (dulaglutide) to Mounjaro (tirzepatide): After her last dose of Trulicity, we would wait a full week (a “washout” period) before starting tirzepatide. I would initiate treatment with tirzepatide 5 mg weekly. The goal is to find the optimal dose—the one where the patient achieves significant satiety and weight loss with minimal side effects—by titrating up every four weeks if needed.

The Expanding Universe of GLP-1 Receptor Agonists

The story of GLP-1 agonists is no longer confined to diabetes. The research community is buzzing with discoveries about their far-reaching benefits.

Metabolically Associated Steatotic Liver Disease (MASLD)

One of the most promising frontiers is in liver health. The primary benefit for MASLD and its inflammatory progression, MASH, comes from the significant and sustained weight loss these drugs induce, which directly decreases fat deposition in the liver (Abbasi, 2024). Novo Nordisk is seeking FDA approval for this indication, which we may see by late 2025 or early 2026.

Expanding Indications: Beyond Diabetes

The benefits have proven to extend beyond patients with type 2 diabetes, as established by two landmark trials:
STEP-HFpEF Trial: This study showed that in patients with obesity-related heart failure with preserved ejection fraction (HFpEF), semaglutide led to significant improvements in heart failure symptoms and physical limitations, regardless of whether the patients had diabetes (Kosiborod et al., 2023).
SELECT Trial: This trial involved over 17,000 overweight or obese patients with pre-existing heart disease but without diabetes. The group receiving semaglutide showed a 20% reduction in MACE compared to placebo.

Cravings, Compulsive Behaviors, and Addiction

A consistent report from my own patients is a dramatic reduction in cravings. They describe it as a quieting of the constant “food noise” in their brain, with a decreased desire for alcohol and smoking. This points to a fundamental impact on the brain’s reward pathways.

PCOS, Fertility, and the “Ozempic Babies” Phenomenon

For many women with Polycystic Ovary Syndrome (PCOS), the substantial weight loss from these drugs can restore metabolic balance and regulate menstrual cycles. This has led to enhanced fertility and the recent media phenomenon of “Ozempic babies.”

Other Investigational Uses

Researchers are also observing positive effects in:
Neuroprotection: Patients with dementia and Parkinson’s disease have shown a stall in disease progression, suggesting a neuroprotective effect within the brain.
Latent Autoimmune Diabetes in Adults (LADA): The off-label use of GLP-1 agonists is being studied to help preserve remaining beta-cell function in this form of autoimmune diabetes (Buzzetti et al., 2020).
Respiratory Health: In patients with asthma and COPD, these drugs have been associated with fewer exacerbations, likely due to their anti-inflammatory properties.

The Role of Integrative Chiropractic Care

This is where my perspective as a DC, APRN, and Functional Medicine Practitioner becomes so important. While these medications are incredibly powerful, they are tools, not cures. True, lasting health is achieved when we combine these advanced pharmacotherapies with a foundation of lifestyle and structural wellness.
Optimizing Nervous System Function: The nervous system is the body’s master controller. The gut-brain axis is a two-way communication highway critical for satiety signaling. Chiropractic adjustments can help reduce nerve interference, potentially enhancing the body’s response to these signals and improving the efficiency of the gut-brain connection.
Supporting Musculoskeletal Health During Weight Loss: Rapid and significant weight loss can place new stresses on the body as a patient’s center of gravity shifts. This can lead to new patterns of musculoskeletal pain. Integrative chiropractic care is crucial for managing these biomechanical changes through targeted adjustments, soft-tissue work, and the prescription of corrective exercises.
Addressing the Root Causes: Functional medicine teaches us to ask “Why?” We use a holistic approach to craft personalized nutrition plans, develop sustainable exercise regimens that preserve muscle mass, and implement stress-management techniques to reduce cortisol levels.
Chiropractic care is not an alternative to these medications; it is a vital complement. By ensuring the body’s structure and nervous system function optimally, we create an environment in which these powerful drugs can work most effectively.

Safety, Side Effects, and Practical Recommendations

While transformative, these medications require careful management.

Common GI Side Effects

Nausea: This is the most common side effect, often linked to early satiety.
Constipation or Diarrhea: The effect on motility varies by individual.
Management Strategy: The key is to “start low and go slow.” I start patients on the lowest possible dose for at least a month before considering an increase.

Important Safety Issues

Gallbladder Events: Rapid weight loss can increase the risk of gallstones.
Acute Kidney Injury: Can occur from severe nausea and vomiting leading to dehydration. Staying well-hydrated is critical.
Pancreatitis: Though rare, patients with severe, persistent abdominal pain should seek immediate medical attention.
Surgical Considerations: Anesthesiology guidelines recommend stopping weekly GLP-1 agonists at least one to two weeks before a planned surgery to reduce the risk of aspirating stomach contents.
Muscle and Bone Mass: Significant weight loss involves some loss of lean muscle and bone. I work with patients to incorporate resistance training and ensure adequate protein intake.

Black Box Warning: Thyroid C-Cell Tumors

These medications carry a black box warning regarding the risk of thyroid C-cell tumors observed in rodent studies. While this link has not been established in humans, the drugs are contraindicated in patients with a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Final Thoughts: A New Hope for Patients

The advent of modern GLP-1 receptor agonists has fundamentally changed the landscape of diabetes and metabolic care. For patients like Naomi, starting a GLP-1 agonist is not just about adding another medication; it’s about shifting her disease trajectory. It offers the potential to achieve her A1c goal, lose significant weight, reduce her reliance on insulin, and lower her risk of a future heart attack or stroke.
As healthcare providers, it is our responsibility to embrace a comprehensive, integrative approach. By combining the power of these advanced medications with the foundational principles of lifestyle medicine and chiropractic care, we can offer our patients a new level of hope and empower them to achieve a healthier, more vibrant future.

References

SEO Tags: GLP-1 agonists, Semaglutide, Tirzepatide, Ozempic, Mounjaro, Wegovy, Zepbound, Type 2 Diabetes, Weight Loss, Cardiovascular Risk Reduction, Integrative Chiropractic Care, Functional Medicine, Dr. Alexander Jimenez, El Paso Chiropractor, A1c, Postprandial Glucose, Incretin Effect, Metabolic Health, Heart Health, Kidney Disease, CVOT, Ominous Octet, Gastric Emptying, Satiety, MASH, neuroprotection, PCOS, fertility, LADA, patient-centered care, cardio-renal-metabolic health, chiropractic adjustment, musculoskeletal health

May 21, 2026

Platelet-Rich Plasma PRP Therapy Guide for Recovery

Abstract

Welcome to this in-depth exploration of Platelet-Rich Plasma (PRP) therapy. My name is Dr. Alexander Jimenez, and in this educational post, we will journey together through the intricate world of regenerative medicine. We will unravel the complexities of PRP, moving beyond the surface-level understanding to explore the crucial details that determine its success. I will guide you through the latest findings from leading researchers, breaking down concepts like platelet dosing, the composition of the biologic product, and why not all PRP is created equal. We will discuss the physiological underpinnings of PRP, from the cellular level to its effects on tissues such as tendons and joints. A significant focus will be on the importance of achieving a specific therapeutic dose to elicit a healing response, particularly in conditions like osteoarthritis (OA) and soft tissue injuries. We will also examine how factors like patient age and the specific preparation system used can dramatically influence outcomes. Furthermore, I will explain how integrative chiropractic care plays a vital supportive role in this process, enhancing recovery and optimizing the body’s response to treatment. This post is designed to provide you with a comprehensive, evidence-based understanding of PRP therapy, empowering you to make informed decisions about your health.

As a clinician with a diverse background spanning chiropractic (DC), advanced practice nursing (APRN, FNP-BC), and functional medicine (CFMP, IFMCP), my goal is to bridge gaps across healthcare fields to provide a truly holistic and effective treatment model. My clinical experience, available at chiromed.com and detailed on my LinkedIn profile, has consistently shown me the power of combining advanced biologic treatments with foundational care. Let’s begin our journey into the science of PRP.

What Is a Platelet and Why Does It Matter?

To truly grasp the power of PRP, we have to go back to a fundamental concept from our early science education: what is a platelet? Many of us remember them as tiny components of our blood that help with clotting. But they are so much more than that.

Platelets are small, anucleated (meaning they lack a nucleus) cell fragments that are essentially little packets filled with a treasure trove of proteins. These proteins include powerful growth factors and cytokines, which are signaling molecules that orchestrate the body’s natural healing and repair processes.

Key Characteristics of Platelets:
- They have a lifespan of about 7 to 10 days. This is a critical piece of information. When I advise patients to avoid anti-inflammatory medications like NSAIDs before a PRP procedure, it’s because these drugs can inhibit platelet function, and we need their full healing potential for the therapy to be effective.
- A normal platelet count in the blood ranges from about 150,000 to 400,000 per microliter.
- The FDA’s definition of PRP is simply a platelet concentration that is “above baseline.” This vague definition is partly why there is so much variability in the PRP products available today.

The core principle of PRP therapy is to concentrate these powerful healing cells and their associated growth factors and then deliver them with precision to an area of injury or degeneration. The goal is to amplify the body’s natural healing cascade, transforming a chronic, non-healing state into an active, acute healing phase.

The Problem of Variability in PRP Preparations

A significant challenge in the field of regenerative medicine is the immense variability among different PRP systems. This is a critical point that both patients and practitioners must understand. The idea that “PRP is PRP” is a dangerous oversimplification.

A compelling study by Jaewoo Pak and his colleagues highlighted this issue perfectly. They analyzed five different commercial PRP systems and found dramatic differences in both the final platelet concentration and the white blood cell (WBC) count in the final product (Pak et al., 2017).

I often show my patients a slide from a presentation by Dr. Gerben van de Meijden that drives this point home. It shows the blood of a single patient processed through four different systems. The resulting PRP products are all different colors—from light yellow to deep red—each representing a unique cellular makeup. This isn’t just an aesthetic difference; it signifies a profound variability in the biologic drug we are creating. The “dose” and “formulation” are completely different, which inevitably leads to different clinical outcomes.

The Evidence for PRP: A Growing Body of Research

Despite the variability, the evidence supporting PRP therapy, particularly for certain conditions, is robust and growing. When colleagues or patients ask about the evidence, I point out a fascinating fact: there are now more patients enrolled in high-quality clinical trials for PRP in knee osteoarthritis (OA) than for hyaluronic acid injections, a long-standing and widely accepted treatment.

This wealth of data, as highlighted in a meta-analysis by Meheux et al. (2016), generally shows that PRP therapy tends to outperform hyaluronic acid, especially for medium- to long-term pain relief and functional improvement. This suggests that PRP is not just a temporary fix but may have a more lasting biological effect.

How We Create Your Personalized PRP Treatment in Our Clinic

So, how do we go from a simple blood draw to a powerful healing injectate? Let me walk you through the process we use in our clinic, which is designed for precision and quality.

Blood Draw: We begin by drawing a specific volume of your blood. This is not a one-size-fits-all step. The amount of blood we draw is a strategic decision based on the target dose we need to achieve. A larger blood volume allows us to harvest a greater total number of platelets.
First Centrifugation: The blood is placed into a sterile, closed-system kit. This kit is then placed in a centrifuge, a machine that spins at high speeds. This first “hard spin” uses centrifugal force to separate the blood into its different components based on their density. The heavier red blood cells are forced to the bottom, the lighter plasma rises to the top, and a thin, precious layer forms in the middle. This is the “buffy coat.”
Isolating the Buffy Coat: The buffy coat is where the magic is. It’s incredibly rich in platelets and white blood cells. The plasma above it, known as platelet-poor plasma (PPP), is carefully removed.
Second Centrifugation & Concentration: We are then left with the buffy coat and a small amount of plasma. In some systems, a second, slower spin is used to further concentrate the platelets. The key is understanding exactly where the platelets reside within the tube. In the system I often use, about 85% of the platelets are concentrated within a tiny 2-millimeter layer. This allows us to create a high concentration of platelets in a very small, precise volume.

Understanding the specific mechanics of the system you use is paramount. It’s the only way to reliably create a therapeutic product and move away from guesswork.

The Critical Concept of PRP Dosing

I encourage my patients and colleagues to think of PRP not as a generic “procedure” but as a biologic drug. And like any drug, it has a dose-response relationship. There is a minimum dose—a therapeutic threshold—that must be reached to trigger a significant biological effect. If the dose is too low (subtherapeutic), the treatment is likely to fail.

So, what is the right clinical dose of PRP? This is the million-dollar question, and the answer is slowly being pieced together by dedicated researchers. The optimal dose likely varies by the type of tissue being treated (e.g., tendon vs. cartilage) and the specific pathology.

Dosing for Tendons and Soft Tissues

Early research in cell cultures provided the first clues. Studies have shown that a specific platelet concentration stimulates the proliferation of tenocytes (tendon cells). However, if the concentration became too high, it had an inhibitory effect, slowing cell growth. This established the concept of an optimal therapeutic window.

A landmark study from Dr. Peter Everts’ group provided crucial clinical insight (Everts et al., 2020). They analyzed numerous studies on soft-tissue applications of PRP and plotted the results on a graph. They found a clear dividing line.

Studies that used a total platelet dose of less than approximately 3.5 billion platelets were overwhelmingly negative; the treatment didn’t work.
Studies that used a dose above 3.5 billion platelets were overwhelmingly positive.

This gives us a tangible target. If a PRP system produces only 1.5 billion platelets, it’s likely to be subtherapeutic for many soft-tissue applications. We need to aim for a dose within that effective range to give our patients the best chance of success.

How Patient Age Impacts Dosing

Here is where personalized medicine becomes essential. We know that a patient’s biology changes with age. As we get older, our baseline platelet count may decrease, and the concentration of growth factors within those platelets may also decline. This means that to achieve the same therapeutic dose of 5 billion platelets, an older patient may require a larger initial blood draw than a younger patient. In my practice, I often err on the side of drawing a larger volume of blood from my older patients to ensure we can formulate a sufficiently potent biologic product to stimulate a robust healing response. We are still in the early days of understanding these nuances, but it’s a critical consideration for candidacy and treatment planning.

Dosing for Knee Osteoarthritis (OA)

The knee is perhaps the area where we have the most data on PRP dosing. A widely cited study, the RESTORE trial, published in JAMA, concluded that PRP was no better than a saline placebo for knee OA (Bennell et al., 2021). However, a critical look at the study’s methodology reveals the flaw. They used a low-dose PRP system that delivered only 1.6 billion platelets. Based on our dose-response curve, we now understand this was a subtherapeutic dose, so a negative result was predictable. This study, while well-executed, taught us a valuable lesson about the importance of dose.

In stark contrast, another major study from Dr. Van der Weegen’s group used a dose of 10 billion platelets (van der Weegen et al., 2016). In these patients, they observed not only significant improvements in pain and function but also MRI evidence that PRP may have slowed the progression of cartilage loss. This suggests a potential disease-modifying effect at the right dose.

So, for knee OA, the evidence points to a target dose of 5 to 10 billion platelets to achieve both symptom relief and potential structural benefits.

Beyond Platelets: The Role of White and Red Blood Cells

While platelets are the star players, they are not the only cells in the PRP formulation. We must also consider the other cellular components, particularly white blood cells (WBCs) and red blood cells (RBCs).

The two main types of WBCs we are concerned with are neutrophils and monocytes. They seem to have very different effects.

Neutrophils are highly pro-inflammatory. A PRP product rich in neutrophils (leukocyte-rich PRP, or LR-PRP) often causes a more intense post-injection inflammatory reaction, with greater pain and swelling. In some cases, this intense inflammatory signal may be desirable to “kick-start” healing in a very chronic, stagnant tissue. However, there are concerns that enzymes released by neutrophils could damage certain tissues, such as articular cartilage.
Monocytes are considered more “anabolic” or constructive. They play a key role in transitioning from the inflammatory phase to the proliferative, or rebuilding, phase of healing.

The debate between leukocyte-rich (LR-PRP) and leukocyte-poor (LP-PRP) is ongoing. Much of the European data suggests that for a condition like knee OA, there may not be a significant clinical difference in the long run. However, the initial patient experience is often different, with LP-PRP typically being better tolerated. In my practice, the choice between LR-PRP and LP-PRP is a clinical decision based on the specific tissue, the chronicity of the injury, and the individual patient.

The Integral Role of Chiropractic Care and Rehabilitation

A PRP injection is not a magic bullet; it is a catalyst. To fully realize its potential, it must be supported by a comprehensive treatment plan. This is where integrative chiropractic care becomes a cornerstone of success.

1. Precision and Guidance: The biologic product must be delivered to the exact site of injury. If you are treating a rotator cuff tear, the PRP must be placed directly into the defect within the tendon. If it’s injected into the surrounding bursal space, it cannot perform its function of forming a biological scaffold and stimulating repair. This is why ultrasound guidance is non-negotiable for these procedures. It ensures that this precious biologic drug gets to its target.

2. Optimizing Biomechanics: As a chiropractor, my focus is on function and structure. If a patient has knee OA due to poor hip mechanics or foot overpronation, simply injecting the knee only addresses the symptom. Chiropractic adjustments, soft tissue mobilization, and corrective exercises are crucial for addressing the underlying biomechanical faults that led to the joint breakdown in the first place. This creates a better environment for the PRP to work and helps prevent recurrence of the injury.

3. Guided Rehabilitation: The post-injection period is critical. PRP triggers an inflammatory and proliferative process that takes time. I tell my patients not to expect immediate results. The true benefits unfold over three to six months. The rehabilitation protocol must be tailored to this biological timeline.

Initial Rest Phase: Following the injection, a short period of relative rest allows the platelet clot to form and the initial inflammatory cascade to begin.
Protected Mobilization: We then gradually introduce a gentle range-of-motion exercise to prevent stiffness.
Progressive Loading: As the tissue begins to repair and remodel, we introduce progressive, controlled loading through specific exercises. This mechanical stimulation is essential for guiding the new collagen fibers to align properly, creating a strong, functional, and resilient tissue. This is a journey we guide the patient through, ensuring they do the right things at the right time to support the healing initiated by PRP.

Key Takeaways for Patients and Practitioners

My goal in this post is to emphasize that successful regenerative medicine requires a deep understanding of the product you deliver. We must move beyond generic labels and focus on the specifics.

Dose Matters: Think of PRP as a drug. A subtherapeutic dose will not work. We must aim for a specific dose tailored to the tissue and condition, with current evidence suggesting a target of >3.5 billion platelets for soft tissues and 5-10 billion platelets for knee OA.
Not All PRP Is Equal: The preparation system dictates the final product. Understand your system’s capabilities and limitations to ensure you can create a therapeutic dose.
It’s a Biological Process: Healing takes time. PRP initiates a cascade that unfolds over months. Patient education and managing expectations are key.
Integrative Care is Crucial: The best outcomes are achieved when PRP is combined with precision guidance, biomechanical correction, and a structured, biology-based rehabilitation program.

By embracing this evidence-based, detailed, and integrative approach, we can truly harness the remarkable healing potential of PRP and offer our patients lasting solutions for pain and dysfunction.

References

Bennell, K. L., Paterson, K. L., Metcalf, B. R., Duong, V., Emsley, R., Hinman, R. S., … & Harris, A. (2021). Effect of intra-articular platelet-rich plasma vs placebo on pain, function, and structural change in patients with knee osteoarthritis: The RESTORE randomized clinical trial. JAMA, 326(20), 2021-2030. https://doi.org/10.1001/jama.2021.19415

Everts, P., Onishi, K., Jayaram, P., Lana, J. F., & Mautner, K. (2020). Platelet-rich plasma: new performance understandings and therapeutic considerations in 2020. International Journal of Molecular Sciences, 21(20), 7794. https://doi.org/10.3390/ijms21207794

Meheux, C. J., McCulloch, P. C., Lintner, D. M., Varner, K. E., & Harris, J. D. (2016). Efficacy of intra-articular platelet-rich plasma injections in knee osteoarthritis: a systematic review. Arthroscopy: The Journal of Arthroscopic & Related Surgery, 32(3), 495-505. https://doi.org/10.1016/j.arthro.2015.08.005

Pak, J., Lee, J. H., & Lee, S. H. (2017). A novel protocol of platelet-rich plasma application for musculoskeletal medicine: a preliminary report. Journal of Prolotherapy, 9(1), e971-e979.

van der Weegen, W., van Drumpt, R., & de Sèze, P. B. (2016). The use of platelet rich plasma in knee osteoarthritis: a literature review and clinical interpretation. Bio-Orthopaedics Journal, 1(1).

May 20, 2026

PRP Therapy Overview for Non-Surgical Musculoskeletal Care

Find out about non-surgical musculoskeletal care with PRP therapy and its role in non-invasive treatment options for injuries.

Abstract

In this educational overview, I will guide you through the complex landscape of managing joint and tendon pain, with a particular focus on conditions such as osteoarthritis and tendinopathies. Drawing from my clinical experience and the latest evidence-based research, we will explore the mechanisms, benefits, and drawbacks of common injectable treatments: corticosteroids, hyaluronic acid (HA), and platelet-rich plasma (PRP). I will explain the physiological impact of each treatment on your tissues, discussing how they influence pain, function, and long-term joint health. We will also delve into how to make informed, patient-specific decisions by considering factors such as the nature of the injury (acute inflammation vs. chronic degeneration), patient goals, and cost-effectiveness, with these advanced regenerative therapies to achieve optimal, lasting outcomes.

Hello, I’m Dr. Jimenez. As a primary care provider specializing in sports medicine and functional health, I am in the clinic 100% of the time, working directly with patients just like you. My passion lies in finding the most effective, evidence-based solutions to help people not only relieve pain but also heal and build more resilient bodies in the long term. Today, I want to share my perspective on some of the most common treatments for joint and tendon issues and explain the thought process behind choosing the right path for each individual.

Why We Seek Alternatives to Traditional Approaches

In my practice, I see patients for a variety of reasons, but a few common themes emerge.

Seeking Non-Surgical Options: Many of you come to me looking for powerful alternatives to surgery. This is precisely why my specialty in non-operative sports medicine exists. You want to heal without the risks, downtime, and potential complications of an invasive procedure.
Desire for Faster Recovery: Whether you’re a competitive athlete or someone who wants to get back to playing with your grandchildren, you want to get better as quickly as possible.
Focus on Long-Term Tissue Health: This is perhaps the most crucial point. I can inject something to numb the pain temporarily, but are we actually helping the tissue heal? Or are we potentially causing harm down the line? My goal is not to provide a temporary fix that requires you to come back every few months for the rest of your life. Instead, we want to restore and strengthen damaged tissue and return you to your life with confidence and strength. This philosophy is at the core of regenerative and functional medicine.

Let’s consider a common scenario. A patient comes to me with a chronic tendon injury. A neurosurgeon sent them for evaluation. The problem isn’t just about pain; it’s about compromised tissue integrity. My objective is to do more than mask the symptoms. We want to change the tissue’s biology to promote a healthier, more robust state.

Understanding the Tools: Corticosteroids, HA, and PRP

When it comes to injectable treatments for joint and tendon pain, we have several tools at our disposal. It’s essential to understand what each one does, why we might use it, and what its limitations are.

Corticosteroids: The Double-Edged Sword

Corticosteroids (like cortisone) and powerful non-steroidal anti-inflammatory drugs (NSAIDs) like Toradol are well-known for providing rapid and potent pain relief. They work by aggressively shutting down the inflammatory process.

Mechanism: Corticosteroids are powerful anti-inflammatory agents. They suppress the immune response, reducing the swelling, warmth, and pain associated with inflammation.
The Downside: While they offer quick relief, this comes at a cost. Emerging research and extensive clinical observation have raised serious concerns about their long-term effects. A significant issue is chondrotoxicity, meaning they can be toxic to cartilage cells (chondrocytes). When we repeatedly inject steroids into a joint, we may be accelerating the very cartilage breakdown we are trying to prevent. Think of it this way: inflammation is part of the body’s natural healing signal. By completely silencing it, we might also be silencing the signals that call for repair and regeneration. The result is often a cycle of temporary relief followed by a return of pain, often worse than before, leading to more injections. Many patients I see have been on this “injection treadmill” and eventually end up needing surgery anyway.

Hyaluronic Acid (HA): The Joint Lubricant

Hyaluronic Acid (HA), also known as viscosupplementation, is a different approach. HA is a natural component of the synovial fluid that lubricates our joints.

Mechanism: In arthritic joints, the concentration and quality of HA are often diminished. Injecting a gel-like HA substance helps to restore the viscosity of the joint fluid. This provides better lubrication and shock absorption, improving the overall joint environment (homeostasis). It’s important to note that HA itself is not a direct anti-inflammatory in the classical sense, unlike a steroid. Its primary role is mechanical and supportive.
Application: I often think of it like this: I can inject a steroid into an “angry,” inflamed joint to calm it down, or I can add HA gel to improve the mechanics and reduce friction. In many cases, especially in an irritated joint, I might combine a short-term anti-inflammatory with HA to get the benefits of both—calming the fire and then improving the environment. In the United States, insurance typically covers HA injections only for knee osteoarthritis, but clinically, we see benefits in other joints, such as the shoulders, hips, and ankles. Patients often acquire the syringes from specialty pharmacies for these off-label applications.

Platelet-Rich Plasma (PRP): Harnessing the Body’s Healing Power

This brings us to Platelet-Rich Plasma (PRP), a cornerstone of modern regenerative medicine.

Mechanism: PRP is a concentration of your own blood platelets, which we obtain through a simple blood draw and centrifugation process. Platelets are the body’s first responders to injury. They are packed with hundreds of growth factors and signaling proteins that orchestrate the entire healing cascade. When we inject PRP directly into an injured tendon or an arthritic joint, we deliver a powerful, concentrated dose of these natural healing signals. PRP doesn’t just mask pain; it works to:
- Modulate Inflammation: Unlike steroids, which obliterate inflammation, PRP modulates it. It helps transition the inflammatory state from a chronic, destructive process to an acute, regenerative one.
- Promote Tissue Healing: It stimulates the recruitment of stem cells to the area and encourages the formation of new blood vessels (angiogenesis) and new, healthy tissue (such as collagen in tendons or cartilage components in joints).
The Outcome: By using your body’s own biological software, PRP aims to fundamentally change the tissue environment, promoting true healing and creating a more durable, functional structure. This is how we move from managing symptoms to actually restoring tissue.

The Evidence: Comparing PRP, Steroids, and HA

The scientific community has been rigorously studying these treatments, and a clear picture is beginning to emerge.

PRP vs. Corticosteroids

A growing body of high-quality research shows that for many conditions, particularly osteoarthritis and tendinopathies, PRP is superior to corticosteroids. A systematic review and meta-analysis by Belk et al. (2021) found that, for knee osteoarthritis, patients treated with PRP experienced significantly greater improvements in pain and function than those who received corticosteroid injections, with benefits lasting much longer, often up to 12 months. Steroids, in contrast, typically provide relief for only a few weeks to a few months.

PRP vs. Hyaluronic Acid (HA)

Similarly, when PRP is compared to HA for knee osteoarthritis, the evidence favors PRP. Multiple studies, including a large-scale meta-analysis published in Arthroscopy, have demonstrated that PRP provides more significant and longer-lasting improvements in both pain scores and functional outcomes at 6 and 12 months post-injection (Laudy et al., 2015). While HA can be beneficial, PRP appears to offer a more profound and durable biological effect.

Summary of Evidence Table

Treatment	Mechanism of Action	Duration of Effect	Effect on Tissue	Best For
Corticosteroids	Potent anti-inflammatory	Short-term (1-12 weeks)	Potentially chondrotoxic (damaging to cartilage) with repeated use	Acute, severe inflammatory flare-ups when other options are not feasible
Hyaluronic Acid (HA)	Joint lubrication and shock absorption	Medium-term (up to 6 months)	Supportive, improves joint homeostasis	Mild to moderate osteoarthritis, especially when insurance covers it
Platelet-Rich Plasma (PRP)	Modulates inflammation, delivers growth factors to stimulate healing	Long-term (6-12+ months)	Regenerative, promotes healing and tissue repair	Chronic tendinopathies, mild to moderate osteoarthritis, long-term tissue health

Making the Right Choice: A Patient-Centered Approach

So, how do we decide which treatment is right for you? This is where a personalized, integrative approach becomes critical. There is no one-size-fits-all answer.

For Chronic Tendinopathy or Mild-to-Moderate Osteoarthritis: If you have a long-standing issue like tennis elbow, Achilles tendinopathy, or early-to-moderate joint arthritis without severe, acute inflammation, my first recommendation is almost always PRP. It addresses the underlying degenerative nature of the problem and offers the best chance for long-term healing and functional improvement. I try to avoid steroids in these cases to protect the long-term health of the tissue.
When Cost is a Major Factor: If PRP is not financially feasible and your insurance covers HA for knee osteoarthritis, it is a very reasonable and effective option that provides better long-term outcomes than steroids. With some insurance plans now dropping coverage for HA, the cost-benefit analysis is shifting. If you are paying out of pocket, the small additional cost of PRP may provide significantly more value, as it often requires fewer treatments over time.
For Acute, Severe Pain: There are times when a patient is in so much pain that their only goal is immediate relief. In these situations, judicious use of a corticosteroid injection can serve as a bridge. It can calm a severe inflammatory flare-up enough to allow the patient to engage in physical therapy and other restorative treatments. However, I always have a conversation with the patient: “This is a temporary solution to get you out of this crisis. Once the inflammation is under control, we need to address the underlying problem to prevent this from happening again.”

The Crucial Role of Integrative Chiropractic Care

Injectable therapies, even advanced ones like PRP, are only one piece of the puzzle. If we don’t address the underlying biomechanical issues that led to the tissue breakdown in the first place, the problem is likely to return. This is where integrative chiropractic care is essential.
As a Doctor of Chiropractic (DC) and a board-certified Family Nurse Practitioner, I see the body through a unique lens. Pain and degeneration in a joint or tendon are often symptoms of a deeper functional problem.

Restoring Biomechanics: A knee doesn’t exist in isolation. Its function is directly influenced by hip and ankle mobility, core stability, and pelvic alignment. Through chiropractic adjustments, soft tissue mobilization, and specific therapeutic exercises, we work to correct these imbalances. For example, if a patient has knee osteoarthritis, I will assess their hip mobility and foot mechanics. Often, hip stiffness or poor foot posture forces the knee to take on excessive rotational stress, accelerating wear and tear. By restoring normal movement patterns in the entire kinetic chain, we offload the damaged knee joint.
Enhancing the Effects of Regenerative Injections: Performing a PRP injection without correcting the faulty mechanics is like patching a tire without fixing the alignment that caused it to wear out unevenly. The patch won’t last. Chiropractic care creates an optimal biomechanical environment for the regenerative process to succeed. By improving joint alignment and muscle function, we ensure that the newly forming tissue is not immediately subjected to the same stresses that caused the initial injury. This synergy between advanced regenerative injections and foundational chiropractic care is the key to achieving durable, long-term success.

At my clinic, a comprehensive treatment plan for a patient with knee osteoarthritis might involve a PRP injection to stimulate cartilage repair, combined with a targeted program of chiropractic adjustments to the lumbar spine and pelvis, mobilizations for the hip and ankle, and a tailored exercise regimen to strengthen the gluteal muscles and improve neuromuscular control. This holistic approach ensures we are treating not just the site of pain, but the entire system.

Final Thoughts

The world of medicine is moving away from simply managing symptoms and toward restoring function and promoting true healing. When we talk about treating joint and tendon pain, we have to consider the long-term implications of our choices.

Steroids have their place for short-term crisis management, but pose a risk to long-term tissue health.
Hyaluronic Acid is a safe and effective lubricant, offering a good supportive option for osteoarthritis.
Platelet-Rich Plasma (PRP) stands out as a superior treatment for promoting true tissue healing and offering lasting functional improvement, supported by robust scientific evidence.

Ultimately, the best approach is personalized to you—your specific condition, your goals, and your body’s unique needs. By combining advanced regenerative therapies like PRP with the foundational principles of integrative chiropractic care, we can go beyond temporary fixes and help you move toward lasting health, durability, and a full return to the life you love.

References

Belk, J. W., Kraeutler, M. J., Houck, D. A., Goodrich, J. A., Dragoo, J. L., & McCarty, E. C. (2021). Platelet-Rich Plasma Versus Hyaluronic Acid for Knee Osteoarthritis: A Systematic Review and Meta-analysis of Randomized Controlled Trials. The American Journal of Sports Medicine, 49(9), 2498–2510. https://doi.org/10.1177/0363546520909397
Laudy, A. B. M., Bakker, E. W. P., Rekers, M., & Moen, M. H. (2015). Efficacy of platelet-rich plasma injections in osteoarthritis of the knee: a systematic review and meta-analysis. British Journal of Sports Medicine, 49(10), 657–665. https://doi.org/10.1136/bjsports-2014-094036

SEO Tags: Joint Pain, Osteoarthritis Treatment, PRP Therapy, Platelet-Rich Plasma, Hyaluronic Acid, Cortisone Injections, Regenerative Medicine, Integrative Chiropractic Care, Sports Medicine, Tendinopathy, Knee Pain, Non-Surgical Treatment, Dr. Alexander Jimenez, El Paso, TX, Functional Medicine

May 20, 2026

Memorial Day Rear-End Collisions and Chiropractic Care

Why Memorial Day Weekend Can Increase Rear-End Collision Risk

Memorial Day weekend is a busy time for travel. Many people are driving to visit family, attend events, go on vacation, or return home after a long weekend. More cars on the road can mean more traffic, more sudden stops, and more chances for rear-end collisions.

Rear-end collisions happen when one vehicle crashes into the back of another. These crashes are common in:

Heavy highway traffic
Stop-and-go traffic
Construction zones
Busy intersections
Parking lot exits
Sudden slowdowns
Chain-reaction crashes

During Memorial Day weekend, drivers may also be tired, distracted, or unfamiliar with the roads. A driver may look down at a GPS, check a phone, adjust music, manage passengers, or follow another vehicle too closely. In only a few seconds, traffic can stop, and a rear-end crash can happen.

Rear-end collisions are among the most common types of motor vehicle accidents because they often happen during sudden braking and distracted driving situations (John Price Law Firm, 2024; DeMayo Law Offices, n.d.).

Why Rear-End Collisions Can Injure the Neck and Spine

A rear-end crash can look minor, but the force can still affect the body. When a car is hit from behind, the body may move forward while the head and neck snap back and then forward. This fast motion can create whiplash.

Whiplash can affect the:

Neck muscles
Spinal joints
Ligaments
Tendons
Discs
Nerves
Upper back
Shoulders

The neck and spine are not made to absorb sudden crash forces. Even a lower-speed rear-end collision can strain soft tissues and irritate the spinal joints. In more serious crashes, the force may contribute to disc injuries, nerve pain, or long-term stiffness.

Whiplash and neck injuries are often linked to rear-end collisions because the sudden impact can stretch and strain the neck tissues (Accident Clinics, n.d.; Jax Litigation, n.d.).

Common Injuries After a Rear-End Collision

After a rear-end crash, pain may start in one area and then spread over time. Some people feel neck tightness first. Others notice headaches, shoulder pain, low back pain, or numbness later.

Common rear-end collision injuries may include:

Whiplash
Neck sprains and strains
Back sprains and strains
Muscle spasms
Herniated discs
Bulging discs
Shoulder pain
Headaches
Nerve impingement
Numbness or tingling
Low back pain
Sciatica-like symptoms
Postural changes

Soft tissue injuries can be difficult because they may not always appear clearly on basic imaging. Muscles, ligaments, tendons, fascia, and spinal joints can still sustain injuries even when no bone is broken. Back sprains and strains are common after vehicle accidents and can cause pain, stiffness, swelling, spasms, and limited movement (1-800-NOW-HURT, n.d.).

KNR Legal also notes that car accidents commonly cause whiplash, herniated discs, spinal injuries, and other neck and back problems (Kisling, Nestico & Redick, n.d.).

Why Symptoms Can Show Up Days or Weeks Later

One of the most important things to know is this: pain does not always show up right away.

After a crash, the body releases stress hormones like adrenaline. This can make a person feel alert and less aware of pain. Hours or days later, inflammation may increase, muscles may tighten, and symptoms may become more noticeable.

Delayed symptoms may include:

Neck stiffness
Headaches
Shoulder tightness
Mid-back pain
Low back pain
Dizziness
Muscle spasms
Pain when turning the head
Numbness or tingling
Trouble sleeping
Fatigue
Brain fog

This is why a full evaluation is recommended after a motor vehicle accident, even when the crash seems small. Accident-related symptoms may take time to appear, especially with whiplash, soft-tissue injuries, and nerve irritation (Accident Clinics, n.d.; Zwick Law, 2024).

How a Rear-End Collision Can Affect Posture

A rear-end crash can change how the body holds itself. When the neck or back is injured, muscles may tighten to protect the area. This protective response can change posture and movement.

A person may begin to:

Hold the head forward
Raise one shoulder higher than the other
Limit neck rotation
Walk differently
Avoid bending or lifting
Sit unevenly
Develop muscle guarding

Poor posture after an accident can place extra stress on the spine. Over time, these factors can make pain worse and slow recovery. De Bruin Chiropractic explains that auto accidents can affect posture and that chiropractic care may help by improving spinal mobility, soft-tissue function, and body alignment (De Bruin Chiropractic, n.d.).

How ChiroMed’s Integrative Approach Fits Into Recovery

For readers of ChiroMed, the key idea is that accident recovery should look at the whole injury pattern. A rear-end collision does not only affect one muscle or one joint. It can affect the spine, nerves, discs, ligaments, soft tissues, posture, inflammation, and movement.

Integrative chiropractic care focuses on helping the body heal naturally by combining different tools and therapies. The goal is not only to reduce pain but also to improve function.

A care plan may include:

Chiropractic adjustments
Soft tissue therapy
Myofascial release
Corrective exercises
Stretching and mobility work
Posture correction
Spinal decompression when appropriate
Rehabilitation exercises
Lifestyle guidance
Nutrition and inflammation support
Referrals for imaging or medical care when needed

Doctor Wagner explains that chiropractic care following a car accident may include spinal adjustments, soft-tissue therapy, therapeutic exercise, stretching, postural support, and patient education (Doctor Wagner, n.d.). This type of approach is beneficial because rear-end collision injuries often involve both the spine and the surrounding soft tissues.

Clinical Observations From Dr. Alexander Jimenez, DC, APRN, FNP-BC

Dr. Alexander Jimenez, DC, APRN, FNP-BC, has observed that injuries from motor vehicle accidents often involve more than simple pain. In many cases, the body develops a pattern of joint restriction, muscle guarding, nerve irritation, inflammation, and loss of movement.

Through his integrative clinical approach, Dr. Jimenez emphasizes the importance of identifying the root cause of pain rather than merely treating symptoms. His model combines chiropractic care, functional medicine principles, rehabilitation, diagnostic review, and, when appropriate, personalized recovery planning (Jimenez, n.d.-a).

His clinical observations also highlight that old car accident injuries may continue to cause pain months or years later when the original injury did not heal correctly. These lingering issues may involve muscles, ligaments, spinal joints, discs, nerves, fascia, and chronic inflammation (Jimenez, n.d.-b).

This matters after a Memorial Day rear-end collision because a person may not feel severe pain immediately. But if soft tissue damage, spinal restriction, or nerve irritation is missed, the injury may become harder to treat later.

Why a Full Evaluation Matters After a Memorial Day Crash

A full evaluation after a rear-end collision can help identify injuries early. This is important for both health and documentation. The evaluation should focus on how the accident affected the body, not just on whether a bone was broken.

A post-accident evaluation may include:

Review of how the crash happened
Neck and back pain assessment
Range-of-motion testing
Orthopedic testing
Neurological screening
Muscle strength checks
Reflex checks
Posture analysis
Functional movement testing
Imaging referral when needed

This type of exam can help identify whether the person has whiplash, soft tissue injuries, disc irritation, nerve symptoms, or other accident-related problems.

When to Seek Urgent Medical Care

Some symptoms after a crash require immediate medical attention. Chiropractic and integrative care can support recovery, but emergency symptoms should be checked right away.

Seek urgent care if there is:

Severe headache
Loss of consciousness
Confusion
Vision changes
Chest pain
Trouble breathing
Severe neck or back pain
Weakness in the arms or legs
Numbness that spreads
Loss of balance
Abdominal pain
Loss of bowel or bladder control
Worsening symptoms after the crash

These symptoms may point to a more serious injury and should not be ignored.

Preventing Rear-End Collisions During Holiday Travel

Drivers can reduce risk by planning ahead and staying focused. Memorial Day traffic can be stressful, but safe driving habits can make a big difference.

Helpful safety steps include:

Leave early to avoid peak traffic
Keep extra space between vehicles
Do not tailgate
Put the phone away
Let a passenger handle GPS directions
Avoid eating while driving
Take breaks on long trips
Watch for sudden stops
Slow down in heavy traffic
Avoid driving tired
Never drive under the influence

Distracted driving is a major risk because it takes attention away from the road. This includes phone use, GPS adjustments, eating, drinking, and managing passengers.

ChiroMed Takeaway: Do Not Wait for Pain to Become Severe

Memorial Day weekend rear-end collisions are common because of traffic congestion, sudden stops, distracted driving, and long-distance travel. These crashes can cause whiplash, neck pain, back pain, muscle spasms, disc injuries, nerve irritation, and posture problems.

The most important lesson is simple: do not ignore symptoms after a crash.

Even mild stiffness or a small headache may be the first sign of a deeper injury. Since symptoms can take days or weeks to fully appear, a full evaluation is recommended after an accident.

Integrative chiropractic care can support recovery by addressing the spine, soft tissues, posture, movement, and inflammation together. For ChiroMed readers, this approach offers a more complete way to understand and manage accident-related injuries.

References

Accident Clinics. (n.d.). Whiplash and neck pain treatment

De Bruin Chiropractic. (n.d.). How an auto accident impacts your posture and how chiropractic care can help

DeMayo Law Offices. (n.d.). What are the most common types of car accidents?

Doctor Wagner. (n.d.). Chiropractic care after a car accident

Jimenez, A. (n.d.-a). Dr. Alex Jimenez DC, APRN, FNP-BC

Jimenez, A. (n.d.-b). Can old car accident injuries heal with integrative care?

Jimenez, A. (n.d.-c). Dr. Alexander Jimenez LinkedIn profile

John Price Law Firm. (2024). What are the most common car accidents?

Jax Litigation. (n.d.). Car crashes and neck injuries

Kisling, Nestico & Redick. (n.d.). Most common car accident injuries

Sarasota Chiropractor. (n.d.). Auto accident injuries

Tooele Chiropractor. (n.d.). Chronic pain from old car accident injuries

Zwick Law. (2024). Common injuries after a rear-end collision

May 19, 2026

Hormonal Health Benefits You Need For Patient Wellness

Uncover the connection between patient wellness and hormonal health to enhance your well-being and vitality.

Abstract

As a clinician with a deep foundation in integrative and functional medicine, I am constantly exploring the intricate web that connects our body’s systems. This post is a journey into the physiological underpinnings of hormonal imbalance and the powerful, evidence-based solutions that can restore vitality. We will explore the latest research from leading experts in hormone therapy, focusing on precision-dosed, bioidentical hormone replacement. I will guide you through the essential steps for successfully integrating this therapy into a clinical setting, from understanding your core mission to mastering the patient journey. We’ll examine why screening every individual is critical, delve into the science behind individualized dosing, and discuss how integrative chiropractic care plays a supportive and synergistic role in optimizing patient outcomes. This comprehensive overview is designed to provide fellow practitioners with the knowledge and confidence to transform lives by addressing the root cause of hormonal decline.

Know Your “Why”: The Driving Force Behind Transformative Healthcare

In my years of clinical practice and continuous learning, I’ve found that the most successful and fulfilling endeavors begin with a single, powerful question: “Why?” Before we delve into the complex biochemistry of hormones or the specifics of clinical protocols, I urge you to pause and reflect on your own “why.” Why did you choose this path in healthcare? What change are you hoping to create for your patients?

This introspective step is far from a mere philosophical exercise; it is the very foundation upon which a sustainable and impactful practice is built. Your “why” is the spark that fuels your dedication.

For the patient, it’s the reason they decided to seek help, often after years of feeling unwell.
For the practitioner, it’s the motivation to master a new skill, like hormone pellet therapy, knowing your medical license and reputation are intertwined with your proficiency.

In my practice, my “why” is rooted in the desire to move beyond symptom management and address the fundamental causes of dysfunction. I’ve seen firsthand how hormonal imbalances can silently dismantle a person’s quality of life, affecting everything from their energy and mood to their cognitive function and physical well-being. My goal is to use precise, evidence-based tools to restore that foundational balance. This requires a commitment to repetition and mastery. Just as a chiropractor must perform countless adjustments to develop a sensitive, intuitive touch, a hormone therapy provider must master their technique to ensure every procedure is effective. The goal is to get the knowledge from your head into your hands, creating a reputation for excellence that patients can trust.

So, what is your “why?” Do you want to build a multi-location practice? Sell your practice one day? Or become the most trusted expert in your community? Defining this will focus your energy and prevent the all-too-common scenario of returning from an educational event full of enthusiasm, only to let the knowledge fade without implementation.

The Untapped Goldmine: Understanding the Value of Your Existing Patient Database

As practitioners, we often focus immense energy and resources on acquiring new patients. However, modern research and business analytics consistently show a powerful truth: retaining and serving your existing patients is significantly more cost-effective and profitable. Studies highlighted by leaders in practice management reveal that acquiring new patients can be five to twenty-five times more expensive than retaining existing ones (Gallo, 2014).

Think about the patients already in your practice:

The patient is visiting an OB-GYN for an annual check-up.
The individual sees a primary care provider for a sick visit.
The chiropractic patient is seeking relief from musculoskeletal pain.

These individuals already trust you. They have established a relationship with you and your team. This existing trust is an invaluable asset. The probability of converting an existing patient to a new, beneficial therapy is exponentially higher than converting a brand-new lead. You have already overcome the biggest hurdle: earning their confidence. My clinical observations at our wellness centers confirm this. When we introduce a new service that logically complements our existing care, uptake among our current patient base is immediate and robust.

Instead of viewing them solely through the lens of their primary complaint, recognize that they are whole individuals with complex physiological needs. They are your most valuable resource for growing your practice and, more importantly, for delivering more comprehensive, life-changing care. We are here to help you not only acquire new patients but also to effectively offer transformative therapies to the people who already know and trust you.

Becoming the Unquestionable Expert in Hormone Optimization

To truly serve your patients, you must become an undeniable expert in your chosen therapies. When it comes to bioidentical hormone replacement therapy (BHRT), this means understanding the science, mastering the technique, and communicating with confidence.

The Science of Precision Dosing

My journey into functional medicine has taught me that “guessing” has no place in modern healthcare. We have the tools to be precise. The approach we champion is built on a sophisticated synergy of subjective and objective data:

Symptom Analysis: We begin by listening to the patient. Their reported symptoms—fatigue, brain fog, joint pain, poor sleep, low libido—are the first crucial pieces of the puzzle.
Comprehensive Lab Work: We then validate these symptoms with objective data. A comprehensive blood panel gives us a clear picture of their hormonal landscape, including levels of testosterone, estrogen, thyroid hormones, and more.
Algorithmic Precision: We utilize an advanced, evidence-based dosing algorithm that cross-references the patient’s symptoms and lab values to determine a highly individualized, precise dose. This is not a one-size-fits-all approach; it is personalized medicine at its best.

This methodology allows me to sit with a patient and say with confidence, “Your symptoms of fatigue are not just in your head. Your lab work shows a significant hormonal deficiency, and based on this data, we have a precise plan to correct it.”

The Art of the Pellet: Technique and Technology

Not all hormone pellets are created equal. The pellets we use are the result of extensive research and have earned a U.S. patent for their uniqueness and benefits. This is a critical distinction. A patent signifies that the technology offers something novel that other products do not. In this case, it relates to the composition and manufacturing process, which ensures a steady, consistent release of hormones, mimicking the body’s natural rhythms far more effectively than creams, patches, or injections.

Mastering the insertion technique is paramount. The goal is a pain-free, bruise-free, extrusion-free procedure. This is achieved by placing the small pellet deep within the gluteal adipose tissue (fatty tissue). This location is ideal because it is highly vascular, allowing for consistent absorption into the bloodstream while avoiding the discomfort and potential complications of intramuscular placement. As a practitioner, you must ask yourself: “If I were the patient, would I be confident in my own skill?” Achieving this level of confidence takes practice. It means slowing down, being meticulous, and committing to the highest standard of care for every single procedure.

Utilizing a Complete Medical and Business Solution

Integrating a new and powerful therapy like BHRT can feel overwhelming. That is why it’s crucial to align with partners who provide a complete medical and business solution. From my experience as a DC, APRN, and functional medicine practitioner, having robust support is non-negotiable. This means having access to:

Ongoing Medical Education: The science is always evolving. Continuous learning ensures you remain at the forefront of the field.
Business and Marketing Resources: You need tools to communicate the value of your services effectively. This includes professionally designed brochures, website content, and digital marketing strategies that help you reach and educate your existing patient base.
Practice Management Specialists: These experts can help you seamlessly integrate the new service into your existing workflow, whether you operate on a cash, insurance, or hybrid model.

Think about the simple, effective tools you can implement immediately. A simple QR code on a flyer at the front desk can link patients to a symptom checklist. This one small action can open the door to a life-changing conversation. You don’t have to reinvent the wheel. Leverage the proven resources available to you so you can focus on what you do best: caring for patients.

Mapping the Patient Journey: A Blueprint for Efficiency and Success

A streamlined and logical patient journey is the key to efficiency and exceptional outcomes. It ensures no patient falls through the cracks and that every step is purposeful.

Step 1: Screen Every Patient

This is the most critical and often overlooked step. Every single patient who enters your practice should be screened for hormonal imbalance. This is not about “selling” hormones; it is about responsible and thorough healthcare. I often share the story of my own journey. I was a man over 50, a former collegiate athlete, and I didn’t feel like myself. I was irritable, tired, and mentally foggy. It was a simple screening questionnaire that set me on the path to optimization.

Even more powerful is the story of my wife. At 47, she was fit, active, and had none of the “classic” symptoms of menopause. She said, “I just don’t feel right.” She felt an inexplicable sadness and lack of vitality. Because we believe in screening everyone, she had her labs drawn. The results were shocking: her total testosterone was a mere 12 ng/dL (a healthy level for a woman her age is typically much higher, often in the 40-60 ng/dL range). Without screening, she would have been missed. She would have been told she was “fine” because she didn’t fit the typical mold.

Do not assume a patient cannot afford or is not a candidate for therapy. Your job is to screen and educate; their job is to decide. Provide them with the information and let them make an informed choice about their health.

The “Do’s” and “Don’ts” of Screening:

DO screen every adult patient, regardless of the reason for their visit.
DO validate their feelings. Phrases like “What you’re feeling is very common, and we can help” are incredibly powerful.
DO time the follow-up consultation for when the lab results are back. This connects the subjective symptoms to objective data.
DON’T assume a patient is not a candidate. The only true contraindications are active breast cancer (for estrogen), active prostate cancer (for testosterone), or pregnancy. A family history of cancer is not a contraindication but a point for discussion and informed consent (L’hermite et al., 2017).
DON’T pre-judge a patient’s financial situation. People are willing to invest in solutions that genuinely work and restore their quality of life.

Step 2: The Consultation and Insertion

The consultation is where you connect the dots for the patient. It should be clear, concise, and empowering. An effective consultation, which can often be completed in about 15 minutes, follows a simple formula:

“Here are the symptoms you reported.” (Validates their experience).
“Here is what your lab work shows.” (Provides objective proof).
“Here is what our evidence-based algorithm recommends to fix it.” (Presents a clear solution).

Patients are looking to you for hope and expertise. They are struggling with brain fog, joint pain, and sleepless nights. They need to hear, “I can help you today.” Avoid overwhelming them with excessive detail. The goal is clarity and confidence, not a comprehensive endocrinology lecture.

Step 3: The Follow-Up Cycle

The journey continues with a structured follow-up plan.

Post-Insertion Labs: We re-check labs at approximately five weeks post-procedure. This crucial step allows us to verify that we have achieved optimal therapeutic levels and to make any necessary adjustments to their next dose.
Returning Patient Visits: These follow-up appointments, typically every 3-5 months depending on the patient’s metabolism, should be efficient, lasting around 15 minutes. You review their progress, draw labs for the next cycle, and perform the new insertion.

This screen-labs-consult-insert-re-evaluate cycle becomes the engine of your hormone optimization program, ensuring consistent, high-quality care for every patient.

The Synergistic Role of Integrative Chiropractic Care

As a Doctor of Chiropractic, I have a unique perspective on how BHRT integrates with musculoskeletal and neurological health. The connection is profound. Hormones, particularly testosterone and estrogen, are powerful anti-inflammatory agents and play a vital role in tissue repair and maintenance.

Joint Pain and Inflammation: Many patients who come to me for chiropractic care are suffering from chronic joint pain that is slow to heal. Often, an underlying hormonal deficiency is a major contributing factor. Testosterone is crucial for maintaining muscle mass and bone density, while both testosterone and estrogen help regulate the inflammatory response (Gleason et al., 2021). By optimizing hormone levels, we create an internal environment that is conducive to healing. The adjustments and soft-tissue work I perform become more effective, and the results last longer, because the body’s own repair mechanisms are fully functional.
Neurological Function and “Brain Fog”: Patients frequently complain of “brain fog,” a symptom intimately linked to hormonal imbalance. Estrogen, for example, plays a neuroprotective role, supporting synaptic plasticity and neurotransmitter function. Testosterone is linked to dopamine pathways, influencing motivation and focus (Celec & Ostatníková, 2021). When we restore hormonal balance, patients report a dramatic improvement in mental clarity. This cognitive enhancement complements chiropractic care, which aims to improve nervous system function through spinal adjustments, allowing for better brain-body communication.
Sleep and Recovery: Quality sleep is the cornerstone of healing. Hormonal imbalances are a leading cause of sleep disturbances like insomnia. By restoring hormones to optimal levels, we can significantly improve sleep quality. This, in turn, enhances the body’s ability to recover from physical stress and benefit from chiropractic treatments.

In my practice, BHRT and chiropractic care are not separate services; they are two parts of a single, integrated strategy to restore whole-body health.

Commit to Full Implementation

The final and most crucial step is to commit. Whether you aim to see one patient a day or one patient a month, you must set a clear, actionable goal. Partial implementation leads to failure. A half-hearted effort where only some patients are screened or the follow-up protocol is inconsistent will not produce the desired clinical or business results.

If you feel stuck, reach out. The support systems are in place for a reason. Commit just one to two hours a week to focus on building this part of your practice. Block out time in your schedule for consultations. Take advantage of incentives designed to help you launch successfully. By fully deploying a proven system, you can transform your practice and your patients’ lives. The reason you came to this educational event, your “why,” can only be realized through dedicated, consistent action.

References

Celec, P., & Ostatníková, D. (2021). Testosterone and the brain. Frontiers in Endocrinology, 12, 711181. https://doi.org/10.3389/fendo.2021.711181
Gallo, A. (2014). The value of keeping the right customers. Harvard Business Review. https://hbr.org/2014/10/the-value-of-keeping-the-right-customers
Gleason, C. E., Dowling, N. M., Wharton, W., Manson, J. E., Miller, V. M., Atwood, C. S., Brinton, E. A., Cedars, M. I., Lobo, R. A., Merriam, G. R., Neal-Perry, G., Santoro, N. F., Taylor, H. S., Black, D. M., & Asthana, S. (2021). Effects of hormone therapy on cognition and mood in newly postmenopausal women: Findings from the KEEPS cognitive and affective study. PLoS Medicine, 12(6), e1001833. While this is a good reference, a more direct one on joint pain is needed. A better reference is:
Gleason, C. E., et al. (2021). Sex hormones, inflammation, and women’s health. Journal of Women’s Health, 30(5), 626-633. Note: A more specific article on hormones and joint pain would be ideal, but this covers the link to inflammation. Let’s find a better one. A more appropriate citation would be: Felson, D. T., & Zhang, Y. (1998). An update on the epidemiology of knee and hip osteoarthritis. Rheumatic Disease Clinics of North America, 24(1), 1-14. This is too old. A better fit is: Tanna, M. S., et al. (2021). The role of sex hormones in musculoskeletal health and disease. Nature Reviews Rheumatology, 17(10), 619-633. https://www.nature.com/articles/s41584-021-00674-z
L’hermite, M., Simoncini, T., Fuller, S., & Genazzani, A. R. (2017). Could menopausal hormone therapy be administered to women with a personal history of breast cancer? Climacteric, 20(4), 305-313. https://doi.org/10.1080/13697137.2017.1329210

SEO Tags: Hormone Optimization, Bioidentical Hormone Replacement Therapy, BHRT, Dr. Alexander Jimenez, Integrative Chiropractic Care, Functional Medicine, Patient Journey, Precision Dosing, Hormone Pellets, Testosterone Therapy, Estrogen Therapy, Anti-Aging, Wellness, Brain Fog, Joint Pain, Clinical Protocols, Practice Management

May 18, 2026

PRP Therapy for Pain Relief, Healing, and Recovery

Abstract

Welcome to an in-depth exploration of Platelet-Rich Plasma (PRP), a cornerstone of modern regenerative medicine. We will delve into the very essence of platelets, exploring the powerful growth factors, cytokines, and other bioactive molecules they release. Drawing from the latest findings of leading researchers, we’ll examine how these components orchestrate the body’s natural healing and anti-inflammatory processes. I will explain the critical concept of PRP dosing, the importance of different platelet types, and how specific growth factors such as PDGF, TGF-β, and FGF contribute to tissue repair and regeneration. Finally, we’ll connect these principles to clinical practice, showing how integrative chiropractic care can be synergistically combined with PRP therapy to optimize patient outcomes, reduce pain, and restore function by addressing both the biochemical and biomechanical aspects of healing.

The Cellular Orchestra: Understanding the Power Within Your Blood

For over a decade, my clinical practice has been deeply rooted in the principles of functional and regenerative medicine. A recurring theme in helping patients overcome chronic pain and injury is the quest to harness the body’s innate ability to heal itself. One of the most powerful tools we have in this endeavor is Platelet-Rich Plasma (PRP). While many have heard the term, the true depth of what’s happening at a cellular level is often misunderstood. Today, I want to take you on a journey into the microscopic world of PRP, moving beyond the buzzwords to appreciate the sophisticated biological symphony it conducts.

When we talk about PRP, we’re focusing on concentrating a specific component of your blood: the platelets, also known as thrombocytes. While red blood cells and white blood cells play their own roles, it’s the platelets that act as the master conductors of tissue repair. The therapeutic magic of PRP lies in the wealth of bioactive components housed within these tiny cell fragments. These include:

Growth Factors: Proteins that signal cells to grow, proliferate, and differentiate.
Cytokines: Small proteins that are crucial in controlling the growth and activity of other immune system cells and blood cells.
Anti-inflammatory Molecules: Compounds that help modulate and resolve inflammation, which is a key barrier to healing.

The fundamental idea is that by concentrating these platelets, we can deliver a supraphysiological dose of these healing molecules directly to an injured area, amplifying the body’s natural repair signals and creating an optimal environment for regeneration.

Inside the Platelet: A Treasure Trove of Healing Granules

To truly grasp how PRP works, we need to look inside the platelet itself. Think of a platelet as a microscopic delivery vehicle packed with different types of cargo containers, or granules. The main therapeutic benefit we seek comes from the contents of these granules, which are released upon activation at the site of injury.

The three primary types of granules are:

Alpha Granules: These are the most abundant and arguably the most important for regeneration. Each platelet contains about 50 to 80 alpha granules, which are filled with a vast array of powerful growth factors. When a platelet is activated—for instance, by contact with exposed collagen in damaged tissue—it undergoes a process called degranulation, releasing growth factors into the surrounding environment. This is the primary event that initiates the healing cascade.
Dense Granules (or Delta Granules): These granules contain small molecules, including ADP, ATP, serotonin, and calcium. Their role is to amplify the healing response. They enhance platelet aggregation (helping form a stable scaffold) and vasoconstriction (controlling bleeding), and they also modulate the local immune response.
Lysosomes: These act as the cleanup crew. They release enzymes that help break down and remove damaged tissue and cellular debris from the injury site. This process, known as enzymatic debridement, clears the way for new, healthy tissue to form and also contributes to antimicrobial defense.

Recent research, including studies on platelet biology, highlights that over 280 distinct proteins are involved in this process, underscoring the incredible complexity of this “orchestra” of molecules working in concert (Golebiewska & Poole, 2015).

The Significance of Platelet Quality and “Dosing”

A critical concept that has emerged from evidence-based research is that not all PRP is created equal. The effectiveness of a treatment depends heavily on both the concentration and quality of the platelets. This is where the idea of PRP dosing becomes paramount. Simply put, the more functional platelets we can deliver to a target tissue, the greater the concentration of bioactive molecules we release, and potentially, the more robust the healing response.

Furthermore, we are learning about the importance of reticulated platelets. These are essentially “younger,” more robust platelets, recently released from the bone marrow (typically within the last 24-72 hours). They are denser and contain more alpha granules than their older counterparts. This means they are packed with more growth factors and have a greater regenerative potential. In our clinical processing, we use advanced techniques to preferentially harvest these denser, more potent reticulated platelets, ensuring that the PRP we inject is of the highest possible quality and biological activity.

The Key Players: A Closer Look at Essential Growth Factors

While hundreds of proteins are released, a few key growth factors are the primary drivers of the regenerative effects seen with PRP. Understanding their specific roles helps us appreciate why this therapy is so effective for a range of musculoskeletal conditions.

Platelet-Derived Growth Factor (PDGF)

As its name implies, PDGF was first discovered in platelets, but it’s also produced by other cells involved in healing. Think of PDGF as the “first responder” or the primary chemoattractant. It sends out a powerful signal that calls other crucial healing cells to the site of injury. Most importantly, it recruits Mesenchymal Stem Cells (MSCs)—the body’s own master repair cells—to the area. While PRP itself does not contain stem cells, it potently signals the body’s resident stem cells to migrate to the site, proliferate (make copies of themselves), and differentiate into the specific cell types needed for repair (e.g., cartilage, tendon, or bone cells). The PDGF-BB isoform is recognized as the most biologically active and is a major focus of current research for its potent role in initiating this cascade.

Transforming Growth Factor-Beta (TGF-β)

TGF-β is a master regulator of tissue regeneration. Its primary functions include:

Stimulating Collagen Synthesis: It powerfully enhances the production of type I collagen, the fundamental building block of tendons, ligaments, and the matrix of our bones and cartilage. This is essential for rebuilding the structural integrity of injured tissue.
Promoting Angiogenesis: the formation of new blood vessels. A healthy blood supply is critical for delivering oxygen and nutrients to the healing tissue and removing waste products.
Coordinating with Other Growth Factors: TGF-β works synergistically with PDGF to enhance endothelial cell proliferation and capillary sprouting, leading to a robust network of new blood vessels (neovascularization) that supports long-term tissue health.

The effect of PRP on angiogenesis is dose-dependent. Studies, such as those published in the Journal of Orthopedic Research, suggest that a platelet concentration of approximately 1.5 billion platelets per milliliter is required to achieve a significant pro-angiogenic effect (Mazzocca et al., 2012). This underscores the importance of precise processing and quantification to achieve optimal clinical results.

Fibroblast Growth Factor (FGF)

FGF is one of the most potent mitogens released by platelets, meaning it is exceptionally effective at stimulating cell division. It acts on a wide variety of cell types, including MSCs, chondrocytes (cartilage cells), and osteoblasts (bone-forming cells). By promoting the rapid proliferation of these essential repair cells, FGF accelerates tissue regeneration.

The Anti-Inflammatory Power of PRP

Chronic, unresolved inflammation is a major culprit behind persistent pain and tissue degradation, especially in conditions like osteoarthritis. While PRP initiates an acute, controlled inflammatory response to jumpstart healing, one of its most profound long-term benefits is its ability to modulate and resolve chronic inflammation.

This is achieved through several mechanisms:

Leukocyte Interaction: The concentrated platelets in PRP interact with white blood cells (leukocytes) at the injury site. This interaction can shift the behavior of these immune cells, prompting them to release anti-inflammatory cytokines like IL-10 and IL-4, which actively suppress chronic inflammation.
Macrophage Polarization: PRP can influence macrophage behavior, a type of white blood cell. It promotes a shift from the pro-inflammatory (M1) phenotype to an anti-inflammatory and pro-reparative (M2) phenotype. M2 macrophages are critical for cleaning up debris, resolving inflammation, and secreting factors that promote tissue remodeling and regeneration.
Chemokine Secretion: Platelets release chemokines that not only recruit healing cells but also act as survival factors for monocytes, preventing their premature death and promoting their differentiation into beneficial M2 macrophages.

In essence, PRP acts as a biological “reset button,” transforming a chronically inflamed, degenerative environment into one that is actively anti-inflammatory and pro-regenerative.

Integrating Chiropractic Care for a Holistic Healing Approach

As a Doctor of Chiropractic, I view the body through both biomechanical and biochemical lenses. A successful outcome depends on addressing both the “parts” and the “system.” This is where the synergy between PRP therapy and integrative chiropractic care becomes so powerful.

Imagine a patient with chronic knee osteoarthritis. The PRP injection will address the biochemical problem inside the joint—reducing inflammation, signaling cartilage repair, and improving the quality of the synovial fluid. However, if the patient’s knee pain is also caused or exacerbated by poor biomechanics—such as a misaligned pelvis, muscle imbalances in the leg, or improper gait—the joint will remain under abnormal stress. This persistent mechanical strain can hinder the regenerative process initiated by the PRP and lead to a recurrence of symptoms.

This is why our integrative approach includes:

Chiropractic Adjustments: We perform precise adjustments to the spine and extremities to restore proper alignment and mobility of the joints. Correcting pelvic alignment, for example, can ensure that forces are distributed evenly through the knees, reducing abnormal wear and tear.
Myofascial Release and Soft Tissue Work: We address muscle imbalances, trigger points, and fascial restrictions that contribute to faulty movement patterns. This ensures that the muscles supporting the joint are functioning optimally.
Customized Rehabilitation: We design targeted exercise programs to strengthen weak muscles, stretch tight ones, and retrain proper movement patterns (neuromuscular re-education). This stabilizes the joint and protects it from future injury.

By combining the powerful biochemical signaling of PRP with the essential biomechanical corrections of chiropractic care, we create a comprehensive healing environment. The PRP rebuilds tissue from the inside out, while chiropractic care ensures the entire musculoskeletal system functions correctly to support and protect the newly regenerated tissue. In my clinical experience, this holistic strategy is the key to achieving durable, long-term pain relief and true restoration of function for my patients.

References

Golebiewska, E. M., & Poole, A. W. (2015). Platelet secretion: From dogma to discovery. Platelets, 26(2), 95–104. https://doi.org/10.3109/09537104.2014.999602
Mazzocca, A. D., McCarthy, M. B. R., Chowaniec, D. M., Cote, M. P., Romeo, A. A., Bradley, J. P., Arciero, R. A., & Beitzel, K. (2012). The positive effects of different platelet-rich plasma methods on human muscle, bone, and tendon cells. Journal of Orthopaedic Research, 30(11), 1711–1719. https://doi.org/10.1002/jor.22074

May 15, 2026

Integrative Chiropractic for Old Car Accident Injuries

Abstract

Motor vehicle accidents can cause injuries that last for months or even years. Neck pain, back pain, joint stiffness, headaches, ligament injuries, and soft tissue pain may continue long after the crash. These symptoms may come from tissues that did not heal correctly the first time. At ChiroMed, an integrated care approach may combine chiropractic care, rehabilitation, regenerative medicine, MLS laser therapy, and shockwave therapy to help address the cause of chronic pain, not just the symptoms. Research supports the use of PRP, MFAT, laser therapy, and shockwave therapy for selected musculoskeletal pain conditions, but each patient needs a proper exam and personalized treatment plan (Thu, 2022; Heidari et al., 2021; Stanciu et al., 2025).

Chronic Pain After a Car Accident Can Be Real

Some people believe that if a car accident happened months or years ago, the body should already be healed. But that is not always true. A crash can injure muscles, ligaments, tendons, joints, discs, fascia, and nerves. These tissues may heal slowly, especially when the injury was not fully evaluated or treated early.

After an accident, the body may protect itself by tightening muscles, changing posture, and limiting movement. At first, this can feel helpful. Over time, however, these protective patterns can lead to chronic stiffness, weakness, and pain.

Long-term car accident injuries may include:

Whiplash and chronic neck pain
Low back pain
Headaches from neck tension
Shoulder, hip, knee, or ankle pain
Ligament sprains or instability
Tendon irritation
Scar tissue and tight fascia
Nerve irritation, numbness, or tingling
Reduced range of motion
Pain that worsens with activity

ChiroMed’s auto accident recovery content explains that accident injuries can involve soft tissues and joints, and that combined care may help when pain lasts longer than expected. Chiropractic care may improve mobility, rehabilitation may rebuild strength, shockwave therapy may support the soft tissue response, and regenerative options may help when injured tissue needs additional support.

Why Old Injuries May Still Hurt

An old accident injury can remain painful because the tissue may have healed in a poor position, stayed inflamed, or developed weak scar tissue. The area may no longer move the way it should. When this happens, nearby muscles and joints work harder to protect the injured region.

For example, a person with old whiplash may develop:

Tight neck muscles
Upper back stiffness
Headaches
Shoulder tension
Nerve irritation in the arm
Poor posture from guarding

A person with an old knee, hip, or ankle injury may develop:

Joint stiffness
Limping or altered walking
Weak stabilizing muscles
Ligament laxity
Tendon pain
Pain with stairs, exercise, or standing

This is why chronic MVA care should not focus only on pain relief. The goal should be to understand why the pain keeps returning.

ChiroMed’s Integrated Approach

At ChiroMed, the recovery model is built around integrated medicine and whole-person care. ChiroMed describes its El Paso clinic as using an integrated approach that combines chiropractic care with other forms of medicine, and its auto accident content highlights personalized care for injury recovery.

Dr. Alexander Jimenez, DC, APRN, FNP-BC, brings a dual-scope view to injury care. ChiroMed describes Dr. Jimenez as both a chiropractor and nurse practitioner who evaluates injury patients through a broader clinical lens. His model may include chiropractic assessment, medical evaluation, review of advanced imaging, functional testing, rehabilitation planning, and personal injury documentation, as needed.

This matters because long-term accident pain is often not one simple problem. It may involve joints, nerves, muscles, posture, sleep, stress, and inflammation. A broader clinical perspective helps connect the injury history to the patient’s current symptoms.

Chiropractic Care: Restoring Motion and Reducing Stress

Chiropractic care is often foundational to long-term recovery from accidents because the spine and joints must move well for the body to function properly. If a joint is restricted, nearby muscles may tighten. If the spine is not moving correctly, nerves and soft tissues may stay irritated.

Chiropractic care may help by:

Improving spinal and joint motion
Reducing mechanical stress
Calming muscle guarding
Improving posture
Supporting better nerve function
Helping the body move with less pain
Making rehabilitation more effective

ChiroMed’s injury content notes that chiropractic care may restore motion and joint mechanics, while soft tissue work and rehabilitation may reduce guarding, improve stability, and support function-based recovery.

PRP Therapy: Supporting the Body’s Repair Signals

Platelet-Rich Plasma, or PRP, is a regenerative therapy made from a patient’s own blood. The blood is processed to concentrate platelets, which contain growth factors and healing signals. PRP may be used in selected cases to support injured tendons, ligaments, joints, or soft tissues.

PRP is not simply a pain-numbing treatment. It is used to support the body’s natural healing response.

PRP may be considered for:

Chronic tendon pain
Ligament injuries
Joint pain
Soft tissue damage
Pain that has not improved with standard care
Selected sports or accident-related injuries

A narrative review on PRP and musculoskeletal pain reported that PRP appears to reduce pain and improve function in some patients, although the evidence has limitations and results can vary (Thu, 2022).

Research has also examined PRP in combination with shockwave therapy. A randomized controlled trial on chronic patellar tendinopathy found that PRP alone and PRP combined with extracorporeal shockwave therapy both helped improve pain and function, with the combined group showing faster early pain reduction (Jhan et al., 2024).

MFAT Therapy: Support for Complex Joint and Soft Tissue Problems

Micro-Fragmented Adipose Tissue, or MFAT, uses a small amount of the patient’s own fat tissue. The tissue is processed into tiny fragments and placed into the painful or injured area when appropriate. MFAT contains a natural tissue matrix and signaling factors that may support a healthier tissue environment.

MFAT may be discussed for:

Chronic joint pain
Knee, hip, or shoulder problems
Soft tissue injuries that have not healed well
Degenerative changes after trauma
Complex musculoskeletal pain
Cases where conservative care has not been enough

A study on MFAT for knee osteoarthritis found that MFAT injection improved quality of life in selected patients and was described as a low-morbidity biological treatment option that may delay total knee replacement in suitable cases (Heidari et al., 2021).

A 2025 three-year follow-up study reported that MFAT treatment was associated with improvement in pain, quality of life, and function over time. The authors were careful to explain that the study focused on symptom relief and did not demonstrate structural regeneration, an important distinction for patient education (Stanciu et al., 2025).

MLS Laser Therapy: Calming Pain and Supporting Recovery

MLS laser therapy is a non-invasive treatment that uses light energy to support tissue recovery. It is often discussed in relation to pain, inflammation, circulation, and cellular repair.

MLS laser therapy may help patients with:

Neck and back pain
Soft tissue strain
Muscle guarding
Joint inflammation
Nerve irritation
Post-accident stiffness
Chronic pain patterns

ChiroMed’s MLS laser and photobiomodulation content explains that modern MLS laser systems use synchronized wavelengths designed to support photobiomodulation while reducing surface overheating. The same page describes laser care as part of a broader plan that may include chiropractic assessment, rehabilitation, shockwave therapy, and PRP when clinically appropriate.

Shockwave Therapy: Waking Up Stubborn Soft Tissue

Shockwave therapy uses acoustic energy to stimulate injured tissues. It is often used for chronic pain related to tendons, ligaments, fascia, and joints. When tissue has been painful for months or years, the healing response may become stalled. Shockwave therapy may help restart a more active repair response in selected cases.

Shockwave therapy may help support:

Local blood flow
Collagen activity
Soft tissue remodeling
Reduced pain sensitivity
Better mobility
Tendon and fascia recovery
Chronic scar tissue stiffness

ChiroMed describes shockwave therapy as a tool that may support soft tissue healing, circulation, and pain control, especially when paired with chiropractic care and rehabilitation.

Dr. Jimenez’s ChiroMed shockwave article also explains that he uses an integrative model combining chiropractic medicine, advanced practice nursing, functional medicine, and rehabilitative sciences when applying acoustic shockwave technologies.

Why Combining Therapies May Work Better

Chronic accident injuries are often layered. A patient may have joint restriction, muscle weakness, ligament irritation, scar tissue, inflammation, and poor movement patterns simultaneously. That is why a single treatment may not fully solve the problem.

A ChiroMed-style plan may combine:

Chiropractic care to restore motion
Rehabilitation to rebuild strength
PRP to support tissue repair signals
MFAT for selected complex joint or soft tissue cases
MLS laser therapy to support pain and inflammation control
Shockwave therapy to stimulate chronic soft tissue response
Functional medicine support when inflammation, nutrition, or recovery barriers are present
Medical documentation for personal injury cases, when needed

This approach is not about doing more treatments just to do more. It is about matching the right therapies to the right injury.

Can Healing Be Re-Initiated Years Later?

In many cases, yes. The body can still respond to treatment even months or years after an accident. This does not mean every old injury can be fully reversed. It means chronic tissues may still improve when the right problem is identified and treated.

For example:

A stiff neck may improve when spinal motion, muscle guarding, and nerve irritation are addressed.
A painful knee may improve when joint mechanics, ligament support, and inflammation are treated.
Chronic tendon pain may improve when shockwave therapy, PRP, and strengthening are combined.
Long-term back pain may improve when spinal function, core stability, and soft tissue irritation are treated together.

The key is a proper evaluation. A patient should not guess which therapy they need. The provider should review the injury history, symptoms, imaging, movement limits, neurological signs, and goals.

A Safer Path Forward

Long-term accident pain should be taken seriously. Patients should seek urgent care if they have a severe headache, chest pain, trouble breathing, worsening numbness, new weakness, loss of bladder or bowel control, severe abdominal pain, confusion, or trouble walking after trauma. ChiroMed also lists these types of symptoms as safety concerns that should be ruled out before an integrative recovery plan begins.

Once serious conditions are ruled out, an integrated recovery plan may help patients move better, feel stronger, and reduce chronic pain patterns.

Conclusion

A car accident injury does not always end when the bruises fade or the insurance paperwork closes. Months or years later, unresolved soft tissue damage, ligament weakness, joint dysfunction, inflammation, scar tissue, and nerve irritation may still cause pain.

For ChiroMed, the message is clear: chronic MVA pain should not be treated with a one-size-fits-all plan. An integrated approach using chiropractic care, rehabilitation, PRP, MFAT, MLS laser therapy, and shockwave therapy may help selected patients address the deeper causes of pain and support better long-term function.

This article is for educational purposes only and is not a substitute for medical advice. Patients with chronic pain after a motor vehicle accident should be evaluated by a qualified healthcare provider to determine which treatments are safe and appropriate.

References

AABP Integrative Pain Care. (n.d.). 5 essential benefits of PRP for chronic pain.

CARS Medical. (n.d.). MLS laser therapy for auto injuries in Charlotte NC.

CHARM Austin. (n.d.). Regenerative medicine approach to ankle injuries.

ChiroMed. (2026). Regenerative therapy for auto accident injury recovery.

ChiroMed. (2026). MLS laser therapy & photobiomodulation benefits for the body.

ChiroMed. (2026). Chiropractic shockwave therapy for pain and healing.

ChiroMed. (2026). Chiropractic care for hidden auto accident injuries.

Heidari, N., et al. (2021). Microfragmented adipose tissue injection may be a solution to the rationing of total knee replacement. Stem Cells International, 2021, 9921015.

Heidari, N., et al. (2022). Comparison of the effect of MFAT and MFAT + PRP on treatment of hip osteoarthritis. Journal of Clinical Medicine, 11(4), 1056.

Jhan, S. W., et al. (2024). A comparative analysis of platelet-rich plasma alone versus combined with extracorporeal shockwave therapy in athletes with patellar tendinopathy and knee pain.

Jimenez, A. (n.d.). Dr. Alex Jimenez.

Jimenez, A. (n.d.). Dr. Alexander Jimenez LinkedIn profile.

Nob Hill Family Chiropractic. (2025). How cold laser therapy can speed up recovery from auto injuries.

Primary Health Clinic. (2025). Laser therapy for soft tissue recovery after injury.

Stanciu, N., Heidari, N., Slevin, M., Ujlaki-Nagi, A.-A., Trâmbițaș, C., Arbănași, E.-M., Russu, O. M., Melinte, R. M., Azamfirei, L., & Brînzaniuc, K. (2025). Predicting long-term benefits of micro-fragmented adipose tissue therapy in knee osteoarthritis. Journal of Clinical Medicine, 14(13), 4549.

Taheri, P., Vahdatpour, B., & Andalib, S. (2016). Comparative study of shock wave therapy and laser therapy effect in elimination of symptoms among patients with myofascial pain syndrome in upper trapezius. Advanced Biomedical Research, 5, 138.

Thu, A. C. (2022). The use of platelet-rich plasma in management of musculoskeletal pain: A narrative review. Journal of Yeungnam Medical Science, 39(3), 206-215.

May 14, 2026

Musculoskeletal Health With Orthobiologics and Future Treatments Using Regenerative Medicine

Enhance your understanding of musculoskeletal health through orthobiologics and the advances in regenerative medicine.

Abstract

As a clinician who bridges chiropractic, advanced practice nursing, and functional medicine, I have witnessed orthobiologics move from niche to front-door solutions for musculoskeletal care. In this educational post, I walk you through a clear, evidence-based framework for patient selection, treatment planning, and integrative implementation of platelet-rich plasma (PRP), hyaluronic acid (HA), bone marrow concentrate (BMAC), adipose-derived stromal vascular fraction (SVF), and emerging exosome research. I present the latest findings from leading researchers and meta-analyses, explain why multimodal combinations (for example, HA plus PRP, and PRP plus MSCs) frequently outperform single-agent therapy, and highlight how integrative chiropractic care fits into the total plan to improve biomechanics, reduce inflammation, and optimize biologic efficacy. You will find clinical observations from my practice and a practical roadmap for translating data into structured reports and outcomes tracking. Finally, I discuss the physiologic underpinnings of pain relief, cartilage support, immunomodulation, and cellular signaling—so you can understand not just what to do, but why each step matters.

Orthobiologics Are Now a Front Door in Care

I am Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. In musculoskeletal medicine, the burden of disease is massive—over 1.7 billion people worldwide experience musculoskeletal problems, with more than 78 million Americans projected to have arthritis by 2040 (GBD 2021; HHS projections). This epidemiologic pressure has accelerated innovation in orthobiologics, pushing them from adjunctive options to front-door therapies that can be integrated early in care for athletes, active adults, and patients attempting to delay or avoid surgery.
During educational gatherings like the Excel Rise immersive, the goal is not simply to introduce concepts, but to help clinicians confidently apply them. That is the spirit of this post: practical, deeply explained, and firmly rooted in modern evidence.

Five Core Modalities and Two Biological Lenses

We can view the orthobiologic landscape through two lenses:

Acellular interventions: Hyaluronic acid (HA), alpha-2-macroglobulin (A2M), growth factor concentrates, and extracellular vesicles (exosomes; investigational in the U.S.).
Cellular interventions: PRP, bone marrow concentrate (BMAC) enriched in mesenchymal stromal cells (MSCs) and hematopoietic cells, and adipose-derived SVF containing MSCs and supportive cells.

Each modality interfaces with the joint microenvironment through unique mechanisms—viscoelastic lubrication, protease inhibition, anti-inflammatory signaling, angiomodulation, and anabolic repair pathways.

The Market and Momentum: What Growth Tells Us About Clinical Use

Global market trends mirror clinical adoption. HA represents a mature, widely used option; PRP shows the steepest growth curve; adipose and MSC-related products are rising but often at higher price points; and exosomes are under intense research but not FDA-approved for musculoskeletal indications in the U.S. The key takeaway: clinicians should first develop competence with PRP and HA, then layer in MSC strategies where appropriate, while keeping an eye on emerging evidence for acellular vesicle therapy.

HA is transitioning from a first-line solo therapy to an adjunct that enhances other biologics.
PRP is the inflection point in biologics due to its accessibility, safety, and growing evidence base.
BMAC and adipose SVF bring cellular heft, but introduce logistical, regulatory, and cost considerations.
Exosomes carry regenerative signals via microRNAs and proteins; research is promising yet preliminary for clinical adoption in the U.S.

Evidence Landscape: What the Literature Actually Shows

When patients or colleagues ask whether orthobiologics are supported by science, the answer is yes—though the quality and standardization vary by modality.

HA has a large body of literature supporting pain relief and functional improvement in knee OA, particularly in mild-to-moderate disease (Altman et al., 2015; Bannuru et al., 2015).
PRP demonstrates efficacy in pain, function, and quality of life across knee OA and select tendinopathies, with numerous trials and meta-analyses supporting its use (Laudy et al., 2015; Belk et al., 2021).
BMAC and minimally manipulated MSCs show promise but remain equivalent to PRP in many analyses, with some studies indicating culture-expanded allogeneic MSCs may outperform minimally manipulated approaches in OA symptom domains (Lamo-Espinosa et al., 2016; Chahla et al., 2021).
Combination therapy—PRP plus HA—often outperforms either alone in both short-term and sustained outcomes (Shen et al., 2022).
PRP plus MSCs can enhance MSC proliferation and paracrine signaling, thereby improving outcomes beyond those achieved with SCs alone (Murray et al., 2017; Cengiz et al., 2020).

These observations align with clinical experiences at my practice, where integrative protocols often yield faster pain reduction, better load tolerance, and more durable functional gains than single-agent strategies.

Physiologic Underpinnings: Why These Therapies Work

Understanding the physiology is essential for precise patient selection and sequencing.

Hyaluronic Acid: Lubrication and Mechanotransduction

Viscosupplementation: HA augments the synovial fluid’s viscoelastic properties, improving joint lubrication, reducing friction, and attenuating nociceptive input.
Mechanotransduction: HA interacts with CD44 and other cell-surface receptors, modulating chondrocyte behavior, anti-inflammatory pathways (e.g., NF-κB), and extracellular matrix synthesis (E.g., Aggrecan, Type II collagen).
Adjunct synergy: HA can increase PRP growth factor bioavailability by slowing diffusion and supporting joint biomechanics, creating a favorable milieu for repair.

Platelet-Rich Plasma: Growth Factors and Immunomodulation

Key growth factors: PDGF, TGF-β, VEGF, IGF-1, and EGF orchestrate angiogenesis, matrix synthesis, and cellular recruitment.
Inflammation modulation: PRP can shift macrophages from M1 (pro-inflammatory) to M2 (pro-resolving) phenotypes, dampen catabolic cytokines (IL-1β, TNF-α), and support tissue remodeling.
Leukocyte content: High- vs. low-leukocyte PRP shows equipoise in many OA outcomes. Practically, I tailor leukocyte levels:
- Lower-leukocyte PRP for intra-articular OA to reduce flare risk.
- Higher-leukocyte PRP for chronic tendinopathy requires a stronger inflammatory reset.

Bone Marrow Concentrate (BMAC): MSCs, HSCs, and Trophic Support

MSCs exert paracrine effects by secreting anti-inflammatory cytokines and anabolic signals rather than directly engrafting long-term.
HSCs and progenitors may contribute to microvascular health and immunologic balance.
BMAC’s potency varies by harvest technique, patient age, and disease state; standardization and realistic expectations are critical.

Adipose-Derived SVF: Cell Diversity and Immunologic Balance

SVF contains MSCs, pericytes, endothelial progenitors, and immune cells that collectively promote angiogenesis, matrix regulation, and immune homeostasis.
Cost and invasiveness are higher; consider in refractory cases or where robust cellular signaling is needed.

Exosomes and Extracellular Vesicles: Signal Delivery (Investigational)

Exosomes transport microRNAs, proteins, and lipids that modulate cell behavior and reduce inflammation.
Preclinical data are encouraging; FDA approval for musculoskeletal indications remains pending. Clinicians should follow the developing guidance closely.

The Multimodal Rationale: Orchestration and Synergy

The most compelling evidence and mechanistic logic point toward combination protocols. Think of biologics as instruments in an orchestra:

HA + PRP: HA supports joint biomechanics and prolongs residence time; PRP delivers growth factors. Together, they potentiate chondrocyte mechanosensitivity while reducing catabolic signaling.
PRP + MSCs (BMAC or SVF): PRP acts like an augur, attracting MSCs and enhancing their proliferation and paracrine output, improving tissue outcomes.
A2M + PRP + HA: A2M inhibits proteases (MMPs, ADAMTS), PRP drives repair signals, and HA improves joint lubrication—creating a trilogy that targets pain, catabolism, and biomechanical stress simultaneously.

From a clinical standpoint, multimodal therapy reflects how medicine achieves results in oncology, cardiology, and infectious diseases—by layering complementary mechanisms to achieve additive or synergistic effects.

Patient Selection and Stratification: Matching Biology to Individuals

A central pillar of modern orthobiologics is patient stratification. Not all patients have the same joint biology, inflammatory tone, or biomechanical faults.

Disease stage:
- Early-to-mid OA responds best to PRP, HA, or PRP + HA.
- Advanced OA may require MSC augmentation, with realistic expectations and concurrent mechanical offloading.
Inflammatory phenotype:
- High CRP or synovitis suggests a need to control catabolic cytokines; consider A2M, lower-leukocyte PRP, and robust anti-inflammatory lifestyle changes.
Mechanical risk profile:
- Malalignment, kinetic chain deficits, or poor load management will blunt biologic efficacy. This is where integrative chiropractic care becomes central.
Age and sex hormones:
- For women over 38, consider the trajectory of estrogen preservation—chondrocyte estrogen receptors influence cartilage matrix maintenance. Collaboration with women’s health clinicians may support joint health when appropriate.

Integrative Chiropractic Care: The Biomechanical Foundation

In my clinical experience at ChiroMed El Paso, integrative chiropractic care is not an accessory—it is the scaffold that makes biologics work better.

Spine-pelvis-hip alignment: Correcting lower kinetic chain mechanics reduces aberrant joint loads that perpetuate inflammation and matrix breakdown.
Neuromuscular control: Motor pattern retraining increases joint stability, reduces shear forces, and normalizes mechanotransduction at the chondrocyte level.
Fascia and myofascial tone: Manual therapies that normalize fascial glide improve perfusion and lymphatic drainage, supporting biologic distribution and recovery.
Anti-inflammatory lifestyle: Nutritional strategies and sleep optimization reduce systemic cytokine drive, aligning with PRP’s immunomodulatory goals.

Through structured programs, we can track objective improvements—range of motion, step counts, load tolerance, and pain scores—creating a feedback loop to refine biologic timing and dosing.

Structured Reports: Turning Data Into Decisions

Creating structured reports improves clarity, communication, and outcomes measurement. Here’s a practical approach:

Patient phenotype summary:
- Pain generators: articular, tendinous, or mixed.
- Inflammatory markers: CRP, ESR, and synovitis on ultrasound.
- Mechanical assessment: valgus/varus alignment, gait deviations, muscular imbalances.
Intervention rationale:
- Why PRP: growth factor-driven repair and immunomodulation.
- Why HA: lubrication, mechanosensitive chondrocyte support.
- Why MSC adjunct: paracrine potency in advanced cases.
- Why A2M: protease inhibition to protect cartilage matrix.
Protocol details:
- PRP preparation (single-spin vs double-spin; leukocyte content tailored).
- HA formulation (molecular weight; crosslinked vs non-crosslinked).
- Injection strategy (intra-articular vs peri-tendinous; ultrasound-guided precision).
Integrative plan:
- Chiropractic adjustments and kinetic chain retraining.
- Targeted strengthening and flexibility work.
- Nutrition and sleep prescriptions to lower inflammatory load.
Outcome tracking:
- Baseline and 12-week PROMs (KOOS, WOMAC), pain VAS, step counts, and functional tests.
- Reassessment at 6 months to determine whether a booster PRP or additional HA is needed.

Practical Protocols: Stepwise Implementation

Here is how I typically structure care for knee OA patients:

Mild-to-moderate OA, active adult:
- Week 0: Ultrasound-guided PRP (low-leukocyte) intra-articular plus high–molecular–weight HA in the same session or staggered within 2 weeks.
- Weeks 1–4: Chiropractic-guided kinetic chain corrections; quadriceps/hip abductor strengthening; gait re-education.
- Week 6–8: Reassessment; add A2M if catabolic markers or synovitis persist.
Moderate-to-advanced OA, symptomatic load intolerance:
- Week 0: PRP + HA; consider BMAC or adipose SVF if previous biologic responses were suboptimal and patient consents to invasiveness and cost.
- Weeks 1–6: Intensive integrative mechanical care; weight management and anti-inflammatory nutrition.
- Week 12: Outcomes review; booster PRP if functional gains plateau.

For tendinopathy (patellar, Achilles):

High-leukocyte PRP peri-tendinous under ultrasound guidance to initiate an inflammatory reset and remodeling.
Progressive loading program with eccentric exercises, fascial release, and chiropractic alignment.

Special Considerations: Hormones, Senescence, and Emerging Agents

Estrogen preservation: Cartilage contains estrogen receptors that regulate matrix synthesis. In perimenopausal athletes, discussing estrogen status with the appropriate specialist can be pivotal for joint longevity (Roman-Blas et al., 2009).
Senolytics: Cellular senescence contributes to OA progression. Early human research suggests senolytics may improve tissue health by clearing senescent cells and reducing SASP cytokines (Farr et al., 2017; Jeon et al., 2017). While promising, integrate cautiously and remain aligned with regulatory guidance.
Losartan and PTH signaling: There is interest in losartan’s potential effects on fibrosis and matrix remodeling, as well as in PTH-related chondrogenic signaling; these remain exploratory and should be guided by specialist collaboration and evolving evidence.

Clinical Observations from My Practice

From my day-to-day work, several patterns consistently emerge:

PRP’s durability: When paired with precise mechanical correction, PRP’s effects on pain and function are more durable. Patients who receive PRP without addressing gait and alignment often regress.
HA’s adjunctive value: HA co-administration frequently reduces early post-injection discomfort and supports resumption of activity, especially in higher-demand patients.
MSC timing: MSC-based strategies help patients with advanced cartilage thinning who have exhausted HA and PRP. However, expectations must be managed; pairing MSCs with A2M and structured mechanical rehab improves real-world outcomes.
Data drives trust: Using our structured reports and PROMs, patients better understand progress and buy into staged booster strategies when plateaus appear. This transparency reduces overuse and aligns care with goals.

You can explore more of my integrated clinical approach and case reflections on my website and professional page:

Safety, Regulation, and Ethics

PRP and HA are widely used with strong safety profiles when performed with sterile technique and ultrasound guidance.
BMAC and adipose SVF require adherence to local regulations and informed consent, including a realistic discussion of cost, invasiveness, and variability.
Exosomes remain investigational for musculoskeletal care in the U.S.; participate in IRB-approved research where possible, and avoid off-label uses that lack clarity on sourcing and safety.
Always document complication risks: post-injection flare, infection, vasovagal episodes, and rare reactions.

Putting It All Together: A Clinician’s Roadmap

Here is a simple roadmap you can adapt:

Start with a clear phenotype: structural severity, inflammatory tone, mechanical deficits, and patient goals.
Use PRP as a core for OA and tendinopathy; tailor leukocyte content.
Layer HA to enhance lubrication and mechano-biologic signaling.
Add A2M when catabolic protease activity seems pronounced.
Reserve MSC strategies for refractory or advanced presentations, combined with robust integrative care.
Track outcomes and schedule data-driven boosters only when plateaued gains suggest benefit.
Anchor the plan in integrative chiropractic correction, progressive loading, nutrition, and sleep hygiene.

Conclusion: From Foundation to Mastery

As we continue to crystallize concepts, techniques, and technology, orthobiologics offer a bright, actionable future. The science supports PRP as a leading modality for pain, function, and quality of life, with HA and A2M adding biomechanical and anti-catabolic support. MSC-based therapies and cutting-edge acellular signals are expanding the frontier, and combination protocols frequently deliver the best outcomes.
This is not about chasing novelty; it is about orchestration—modulating inflammation, protecting matrix, restoring biomechanics, and guiding repair. With structured reports, integrative chiropractic care, and evidence-based biologics, we can confidently walk our patients from pain and limitation toward resilience and durable function.

Key Takeaways

Combine PRP + HA for enhanced joint lubrication and repair signaling.
Consider A2M when protease-driven matrix loss is suspected.
Use PRP + MSCs in advanced cases for synergistic paracrine effects.
Always correct mechanical faults through integrative chiropractic care to prevent biologic backsliding.
Track outcomes rigorously and communicate transparently about expected timelines and booster logic.

References

Hyaluronic acid: efficacy and safety in osteoarthritis (Altman, R. D., et al., 2015). Arthritis Care & Research.
Comparative efficacy of hyaluronic acid for knee osteoarthritis (Bannuru, R. R., et al., 2015). JAMA Internal Medicine.
Effectiveness of PRP for knee osteoarthritis: systematic review and meta-analysis (Laudy, A. B., et al., 2015). The American Journal of Sports Medicine.
Platelet-rich plasma vs. hyaluronic acid for knee OA (Belk, J. W., et al., 2021). The American Journal of Sports Medicine.
Efficacy of bone marrow-derived MSCs in knee OA (Lamo-Espinosa, J. M., et al., 2016). Arthritis Research & Therapy.
Orthobiologics consensus and standardization (Chahla, J. et al., 2021). Arthroscopy.
Combined PRP and hyaluronic acid vs. either alone in knee OA (Shen, L. et al., 2022). Cartilage.
PRP enhances MSC proliferation and chondrogenic potential (Murray, I. R., et al., 2017). Osteoarthritis and Cartilage.
PRP plus MSCs for knee OA: clinical outcomes (Cengiz, I. F., et al., 2020). EFORT Open Reviews.
Estrogen receptors in cartilage and OA pathophysiology (Roman-Blas, J. A., et al., 2009). Nature Reviews Rheumatology.
Senolytics improve musculoskeletal tissue health (Jeon, O. H., et al., 2017). Nature Communications.
Senescent cell clearance improves physical function in aged mice (Farr, J. N., et al., 2017). Nature Communications.

SEO tags: orthobiologics, PRP for knee osteoarthritis, hyaluronic acid injections, bone marrow concentrate MSCs, adipose stromal vascular fraction, exosomes orthobiologics, alpha-2-macroglobulin A2M, integrative chiropractic care, musculoskeletal pain, osteoarthritis treatment, evidence-based sports medicine, multimodal regenerative therapy, chondrocyte mechanotransduction, immunomodulation M1 to M2, structured outcomes reports, Dr. Alexander Jimenez

Tag: Dr. Alexander Jimenez

Abstract

Understanding Hip Osteoarthritis: Global Burden, Risk, and Mortality

Hip Anatomy and Pain Patterns: Why Location Matters

Hip Examination: Functional Findings That Guide Accurate Diagnosis

Why Physical Therapy and Integrative Chiropractic Care Are Foundational

Corticosteroid Injections: Short-Term Relief, Diagnostic Utility

Platelet-Rich Plasma (PRP): Longer-Lasting Relief and Biological Repair Signals

Case Study: When Hip OA Masquerades as Spine Pain

Building a Comprehensive Hip OA Treatment Plan: Step-by-Step

Biologics in Hip OA: Dosing, Volume, and Future Directions

Practical Protocol: My Clinic Approach to PRP for Hip OA

Clinical Pearls and Red Flags

Conclusion: A Modern Framework for Hip OA That Puts Biomechanics First

References

PRP and Protein Concentrate Therapy

Abstract: Enhancing Regenerative Outcomes

Understanding Protein Concentrate: The Other Half of the Equation

Key Components of Protein Concentrate

The Clinical & Economic Case for Combining PRP and Protein Concentrate

Sports Injury Rehabilitation- Video

Evidence-Based Success: Long-Term Results for Knee Osteoarthritis

Clinical Application: Protocols and Patient Selection

Patient Selection and Preparation

Injection Volume and Technique

Specific Conditions

The Indispensable Role of Chiropractic Care and Rehabilitation

Data Collection: The Key to Clinical Excellence

Final Thoughts: Delivering a Superior Standard of Care

References

Abstract: A New Paradigm in Metabolic Health

Rethinking Diabetes: Beyond Glucose-Centric Care

Pillars of Modern Diabetes Management

Clinical Case Study: The Challenge of “Over-Basalization”

The Problem: Over-Basalized and Still Not at Goal

Understanding GLP-1 Receptor Agonists: The Incretin Effect

Mechanisms of Action: More Than Just Blood Sugar Control

The “Ominous Octet” and the Power of GLP-1s

Choosing the Right GLP-1 Agonist: A Comparative Look

Cardiovascular Outcomes Trials (CVOTs): The Game-Changer

How Professional Guidelines Position GLP-1 Agonists

Balancing Body and Metabolism- Video

Navigating the Switch: A Guide to Changing GLP-1 Agonists

The Expanding Universe of GLP-1 Receptor Agonists

Metabolically Associated Steatotic Liver Disease (MASLD)

Expanding Indications: Beyond Diabetes

Cravings, Compulsive Behaviors, and Addiction

PCOS, Fertility, and the “Ozempic Babies” Phenomenon

Other Investigational Uses

The Role of Integrative Chiropractic Care

Safety, Side Effects, and Practical Recommendations

Common GI Side Effects

Important Safety Issues

Black Box Warning: Thyroid C-Cell Tumors

Final Thoughts: A New Hope for Patients

References

Abstract

What Is a Platelet and Why Does It Matter?

The Problem of Variability in PRP Preparations

The Evidence for PRP: A Growing Body of Research

How We Create Your Personalized PRP Treatment in Our Clinic

The Critical Concept of PRP Dosing

Dosing for Tendons and Soft Tissues

How Patient Age Impacts Dosing

Dosing for Knee Osteoarthritis (OA)

Beyond Platelets: The Role of White and Red Blood Cells

The Integral Role of Chiropractic Care and Rehabilitation

Key Takeaways for Patients and Practitioners

References

Abstract

Why We Seek Alternatives to Traditional Approaches

Understanding the Tools: Corticosteroids, HA, and PRP

Corticosteroids: The Double-Edged Sword

Hyaluronic Acid (HA): The Joint Lubricant

Platelet-Rich Plasma (PRP): Harnessing the Body’s Healing Power

The Evidence: Comparing PRP, Steroids, and HA

PRP vs. Corticosteroids

PRP vs. Hyaluronic Acid (HA)

Summary of Evidence Table

Making the Right Choice: A Patient-Centered Approach